Neoplasm (DBCOND0017273)

Identifiers

Synonyms
Neoplastic Disease / Neoplasia / Neoplasms / Tumour / Tumor / Neoplasms of unspecified behavior / Neoplasm (morphologic abnormality) / Neoplasms benign, malignant and unspecified (incl cysts and polyps) / Neoplasm NOS / Neoplastic disease (disorder)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Betamethasone phosphate
A fast acting ester prodrug of a corticosteroid used to treat inflammatory conditions.
Hydrocortisone acetate
A corticosteroid used to treat inflammatory and pruritic corticosteroid-responsive dermatoses and ulcerative colitis.
Prednisolone phosphate
A corticosteroid used to treat inflammation, immune reactions, as well as endocrine or neoplastic conditions.
Thiotepa
An alkylating agent used to prevent graft rejection in stem cell transplantation and to treat a variety of malignancies including certain types of adenocarcinoma and superficial bladder carcinomas.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT02786199
Histological Differentiation Grade Predicted by Ultrasound Backscatterer ImagingNo drug interventionsNot AvailableNot Availableunknown_status
NCT02582827
QUILT-3.014: A Trial of ABI-011 Administered Weekly in Patients With Advanced Solid Tumors or LymphomasNo drug interventionstreatment1withdrawn
NCT05450744
131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2)treatment1recruiting
NCT04084067
Indocyanine Green (ICG) Guided Tumor Resectiondiagnostic1recruiting
NCT02159742
Prospective Follow-up of Outcomes in Patients Receiving Photodynamic Therapy for Neoplastic DiseasesNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03197363
Białystok PLUS - Polish Longitudinal University StudyNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT02049645
The Suitability of Sniff Dog as a Tool in Screening TumorsNo drug interventionsNot AvailableNot Availablerecruiting
NCT02065297
Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD)No drug interventionsNot AvailableNot Availablecompleted
NCT00792649
Comparison Between HD+ Endoscopy and Standard Videoendoscopy in Screening ColonoscopyNo drug interventionsNot AvailableNot Availableunknown_status
NCT02925234
The Drug Rediscovery Protocol (DRUP Trial)treatment2recruiting
NCT00339989
Cervical Cancer Early Endpoints and DeterminantsNo drug interventionsNot AvailableNot Availablecompleted
NCT01523912
Radiofrequency Ablation for the Treatment of Gastric DysplasiaNo drug interventionstreatment4completed
NCT01456143
Optical Imaging of Head and Neck CancerNo drug interventionstreatmentNot Availableterminated
NCT01577251
The Radiation Oncology Registry and Biosample RepositoryNo drug interventionsNot AvailableNot Availablerecruiting
NCT01954836
Short-Term Fasting During Chemotherapy in Patients With Gynecological Cancer- a Randomized Controlled Cross-over TrialNo drug interventionstreatmentNot Availablecompleted
NCT02049658
The Sensitivity and Specificity of Sniff Dog as a Tool in Diagnosing the Suspected Tumor PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT03415126
A Study of ASN007 in Patients With Advanced Solid TumorsNo drug interventionstreatment1completed
NCT05158712
Genetic Factors and Pheochromocytomas in Neoplasia Type 2No drug interventionsNot AvailableNot Availablerecruiting
NCT04341181
ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profilingtreatment2recruiting
NCT03979014
Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative The NOVEL TrialNo drug interventionsprevention3unknown_status
NCT01962103
Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumorstreatment1 / 2completed
NCT00143533
Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumorstreatment1completed
NCT01105533
A Dose Finding Study Of A New Medication, PF-00337210 That Will Possibly Decrease Blood Supply To TumorsNo drug interventionstreatment1completed
NCT02215733
The Use of Angiotensin Receptor Blockers and the Risk of CancerNot AvailableNot Availablecompleted
NCT05013554
Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid TumorsNo drug interventionstreatment1terminated
NCT00496353
MK2461 Phase I/II Study in Patients With Advanced Solid Tumors (MK-2461-002 AM1)(COMPLETED)No drug interventionstreatment1 / 2completed
NCT01269645
Facts and Attitudes About Clinical TrialsNo drug interventionssupportive_careNot Availablecompleted
NCT01942005
EVER/TMC Mutation as Marker of the Risk of Cutaneous Carcinoma in Immunosuppressed PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00026897
Trafficking of Indium-III-Labeled Cultured Immune Cells in Patients Undergoing Immunotherapy for Advanced CancerNo drug interventionstreatment2completed
NCT03099161
Study of Preladenant (MK-3814) Alone and With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3814A-062)treatment1terminated
NCT00004988
Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium BacteriaNo drug interventionstreatment1completed
NCT01395407
Phase I Trial of Stereotactic Radiosurgery Following Surgical Resection of Brain MetastasesNo drug interventionstreatment1completed
NCT00694356
Study of Dalotuzumab (MK-0646) in Adults With Solid Tumors (MK-0646-009)treatment1completed
NCT02440685
A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumorstreatment1 / 2terminated
NCT01441115
ECI301 and Radiation for Advanced or Metastatic Cancertreatment1terminated
NCT02743637
A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumorstreatment1completed
NCT00001500
Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex TraitsNo drug interventionsNot AvailableNot Availablecompleted
NCT00692159
Study of TRC102 in Combination With Pemetrexed in Cancer Patientstreatment1completed
NCT04280159
Modern Hybrid Imaging in Patients With OSCCNo drug interventionsNot AvailableNot Availablecompleted
NCT04717375
Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumorstreatment1 / 2recruiting
NCT02747342
A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate Cancertreatment1completed
NCT00520299
Study of ADI-PEG 20 in Patients With Advanced MelanomaNo drug interventionstreatment1 / 2completed
NCT00105599
Effectiveness of the FairCare System for Patients With Advanced IllnessNo drug interventionsNot Available2completed
NCT02699606
A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Cholangiocarcinomatreatment2completed
NCT00028249
Process and Outcomes of Pain ManagementNo drug interventionsNot AvailableNot Availablecompleted
NCT00001336
In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00199836
A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer.treatment1completed
NCT00026936
A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment PlanningNo drug interventionstreatment2completed
NCT00470613
Safety Study of Infusion of SGT-53 to Treat Solid TumorsNo drug interventionstreatment1completed
NCT00080418
Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancertreatment1completed
NCT00408434
Study of an Experimental New Drug, PPARγ Agonist Taken by Mouth by Participants With Advanced or Metastatic CancerNo drug interventionstreatment1completed
NCT03251924
A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumorstreatment1 / 2terminated
NCT04203524
Procalcitonin and Antimicrobial Utilization in Critically Ill Cancer Patients With SepsisNo drug interventionsdiagnosticNot Availableunknown_status
NCT01104116
Use of PET Imaging to Distinguish Malignant From Benign IPMNNo drug interventionsdiagnosticNot Availableterminated
NCT01457196
Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment DecisionsNo drug interventionsdiagnosticNot Availablecompleted
NCT00321958
Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal CancerNo drug interventionsNot AvailableNot Availableterminated
NCT02536586
A Study of LY3023414 in Japanese Participants With Advanced Cancertreatment1completed
NCT00100139
Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancertreatment1completed
NCT02154022
Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future ToxicityNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT00270166
The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapytreatment3completed
NCT02759666
A Phase I Trial of SHR3162 in Subjects With Advanced Solid Tumorstreatment1completed
NCT00023166
Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomastreatment1terminated
NCT00283465
A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapytreatment4completed
NCT00083720
Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapytreatment2completed
NCT02875327
Linkage of Medicaid Enrollment Information to Surveillance, Epidemiology and End Results DataNo drug interventionsNot AvailableNot Availablecompleted
NCT00062491
Study of Karenitecin (BNP1350) to Treat Malignant Melanomatreatment2completed
NCT05429762
Effect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid Tumorstreatment1terminated
NCT05450562
Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumorstreatment1 / 2recruiting
NCT00001580
Tissue Acquisition for Molecular DiagnosticsNo drug interventionsNot AvailableNot Availablecompleted
NCT02226289
Bevacizumab-containing Regimen for Metastatic Colorectal Cancer Failed to Cytotoxic Treatmenttreatment2unknown_status
NCT00747292
Peri-Operative Management of Patients Undergoing Laparoscopic Colorectal SurgeryNo drug interventionstreatment1 / 2unknown_status
NCT00448344
Family-supported Smoking Cessation for Chronically Ill VeteransNo drug interventionstreatmentNot Availablecompleted
NCT00001444
A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasmstreatment1completed
NCT02759640
A Phase I Trial of HS-10241 in Solid TumorsNo drug interventionstreatment1completed
NCT02578667
Gorbly Compression Device for Use in Image-guided ProceduresNo drug interventionsNot AvailableNot Availablewithdrawn
NCT04142567
Role of the Pharmacist in Detection of Drug Interactions Before Antitumor Treatment InitiationNo drug interventionsNot AvailableNot Availablecompleted
NCT01794104
Indenoisoquinoline LMP400 for Advanced Solid Tumors and LymphomasNo drug interventionstreatment1completed
NCT00573872
A Phase II Study of Spinal RadiosurgeryNo drug interventionstreatmentNot Availablecompleted
NCT00001572
Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotypetreatment1completed
NCT02955446
Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor MalignanciesNot AvailableNot Availableno_longer_available
NCT01163110
Study to Investigate the Therapeutic Role of RNA Fragments in Platelet Production During ChemotherapyNo drug interventionstreatment1completed
NCT00988195
Study of Pegylated Human Recombinant Arginase for Liver Cancertreatment1completed
NCT01708850
Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2)treatment4completed
NCT01117623
Continuous Dosing of BAY73-4506 in Patients With Advanced MalignanciesNot Available1completed
NCT01863303
Epidemiological Study of Colorectal Cancer in WuHanNo drug interventionsNot AvailableNot Availableunknown_status
NCT03637764
Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignanciestreatment1 / 2terminated
NCT01517464
A Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid TumorsNo drug interventionstreatment1completed
NCT02394821
Odor Management in Fungating Wounds Comparing Metronidazole and Polihexanidesupportive_care3completed
NCT05909202
A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) RecipientsNo drug interventionssupportive_careNot Availablerecruiting
NCT00695279
Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked ProductsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00034879
Iressa Expanded Access Program (EAP)treatment3completed
NCT00657254
Extension Program for Bay 43-9006treatment2completed
NCT01104077
Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN)No drug interventionsNot AvailableNot Availablecompleted
NCT02354547
A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumorstreatment1suspended
NCT05101798
The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trialdiagnostic2recruiting
NCT00407498
Open Label Phase I Study of P276-00 in Patients With Advanced Refractory NeoplasmsNo drug interventionstreatment1completed
NCT00226005
PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinomatreatment2completed
NCT02473497
Crizotinib (Xalkori) Expanded Access Protocol For The Treatment Of Adult Or Pediatric PatientsNot AvailableNot Availableno_longer_available
NCT00694083
Study of Ridaforolimus (MK-8669) in Participants With Solid Tumors (MK-8669-003)(COMPLETED)treatment1completed
NCT01920061
A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)basic_science1completed
NCT00026871
Clinical Evaluation of a Laser Heated, Fiberoptic-Coupled Radiation Dose Verification SystemNo drug interventionstreatment1completed
NCT02746185
Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxabantreatment3completed
NCT03547037
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ-63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination With Erdafitinib in Japanese Participants With Advanced Solid Cancerstreatment1completed
NCT02377752
A Study of Olaratumab in Japanese Participants With Advanced Cancertreatment1completed
NCT02450175
Etiology of the Platelet-Cancer Metastatic Pathway - A Study of Inflammatory Markers, Platelet Characteristics and Metastatic Surrogates in Cancer Patients and Controlsbasic_scienceNot Availableunknown_status
NCT02851706
Natural History of and Specimen Banking for People With Tumors of the Central Nervous SystemNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02828449
Assesment of the Implementation of a Therapeutic Educational Intervention Affecting Adherence to Oral ChemotherapyNo drug interventionssupportive_careNot Availableunknown_status
NCT02044536
Current Practice Pattern and Effect of Training in Upper Endoscopic BiopsyNo drug interventionsNot AvailableNot Availablecompleted
NCT01155713
Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumorstreatment1completed
NCT01287013
Comparing Xperguide vs. Conventional Methods During Percutaneous Image Guided ProceduresNo drug interventionsdiagnosticNot Availableterminated
NCT00408018
Phase I Study of P276-00 in Patients With Advanced Refractory NeoplasmsNo drug interventionstreatment1terminated
NCT02304419
A Study of Galunisertib on the Immune System in Participants With Cancerbasic_science1completed
NCT00001341
A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Diseasetreatment1completed
NCT00026858
Total Body Irradiation for Bone Marrow Transplants: Collaborative EffortsNo drug interventionstreatment2completed
NCT00001835
Oxaliplatin in Cancer Patients With Impaired Kidney Functiontreatment1completed
NCT01287286
Cancers Treated With Combination of Antrodia Cinnamomea and ChemotherapyNo drug interventionstreatment2 / 3unknown_status
NCT02117648
A Study of LY2835219 in Participants With Cancerbasic_science1completed
NCT02684266
A Study of SHR6390 in Advanced Solid Tumor Patientstreatment1completed
NCT00961831
Radiation Dosimetry, Metabolism, Safety, Tolerability and Positron Emission Tomography/Computed Tomography (PET/CT) Imaging With BAY 85-8050 in Healthy Volunteers and PatientsNo drug interventionsdiagnostic1completed
NCT00270127
Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapytreatment3completed
NCT01092091
Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002)treatment1 / 2completed
NCT01672944
Evaluating Biobanking Educational ToolsNo drug interventionsotherNot Availablecompleted
NCT00936104
Side Population in Pancreatic Ductal Adenocarcinoma (PDAC)No drug interventionsNot AvailableNot Availablecompleted
NCT01693172
Effect of an Early Mobilization Program on Outcomes After Major Cancer SurgeryNo drug interventionspreventionNot Availableunknown_status
NCT02434146
Topical Phenylephrine Solution in Preventing Oral Mucosa in Bone Marrow Transplant Patients Receiving Cyclophosphamide and Total Body Radiation Therapysupportive_care1 / 2terminated
NCT00001695
Survey of the Use of Alternative Medical Therapies in Adult Cancer Patients Enrolled in Phase I Clinical TrialsNo drug interventionsNot AvailableNot Availablecompleted
NCT00505414
A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphinetreatment3terminated
NCT00001150
Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal VolunteersNo drug interventionsNot AvailableNot Availablecompleted
NCT04138823
A Study to Test Different Doses of BI 891065 Alone and in Combination With BI 754091 in Asian Patients With Different Types of Advanced Cancer (Solid Tumours)treatment1completed
NCT01425008
Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanomatreatment1completed
NCT02514603
A Study of Prexasertib (LY2606368) in Japanese Participants With Advanced Cancerstreatment1completed
NCT02309164
The Use of Acupuncture for Treatment of Chemotherapy-induced Peripheral Neuropathy (CIPN).No drug interventionstreatmentNot Availablecompleted
NCT00725387
Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of MalignancyNo drug interventionsNot AvailableNot Availablecompleted
NCT02307487
Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patientstreatment2completed
NCT00024687
Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: IV Infusion QOD x Six Dosestreatment1withdrawn
NCT02900287
Cancer Survival in Reunion Island , 1998-2008 (SUCRE)No drug interventionsNot AvailableNot Availablecompleted
NCT03266887
Vitamin D Levels and Survival in Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00521287
Impaired Immunity in Patients With Cancer: Influence of Cancer Stage, Chemotherapy, and Cytomegalovirus InfectionNo drug interventionstreatment2unknown_status
NCT01280487
A Safety Study of Oral ZSTK474 in Patients With CancerNo drug interventionstreatment1completed
NCT05887687
68Ga-P3 PET/CT Imaging in MalignancyNo drug interventionsdiagnosticNot Availablerecruiting
NCT03964233
A Study in Patients With Different Types of Advanced Cancer (Solid Tumors) to Test Different Doses of BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab) and BI 754111 or BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab)treatment1active_not_recruiting
NCT01362933
National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00767533
Immunobiology of CancerNo drug interventionsNot AvailableNot Availableterminated
NCT01323933
First-in-human Study of AB0024 to Evaluate Safety and Tolerability in Adults With Advanced Solid TumorsNo drug interventionstreatment1completed
NCT02817633
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)treatment1recruiting
NCT01695733
Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapysupportive_care1terminated
NCT00559533
A Study of RO5045337 [RG7112] in Patients With Advanced Solid Tumorstreatment1completed
NCT02943733
Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETstreatment1terminated
NCT00879554
A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid TumorsNo drug interventionstreatment1completed
NCT03343054
A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumorstreatment1completed
NCT02390154
Roniciclib Mass Balance Studytreatment1completed
NCT02391454
Self-monitoring Physical Activity With a SMARTphone Application in Cancer Patients: a Feasibility Study (SMART)No drug interventionssupportive_careNot Availablecompleted
NCT05277051
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumorstreatment1recruiting
NCT04572451
Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanomatreatment1recruiting
NCT00165451
A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancerdiagnostic2completed
NCT06546553
A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.treatment1 / 2not_yet_recruiting
NCT00894153
p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced StageNo drug interventionstreatment4unknown_status
NCT01286753
A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutationtreatment2completed
NCT01022853
Combination of BI6727 (Volasertib) and BIBF1120 in Solid Tumorstreatment1completed
NCT02516553
BI 894999 First in Human Dose Finding Study in Advanced MalignanciesNo drug interventionstreatment1completed
NCT02471053
Exercise to Prevent AnthrCycline-based Cardio-Toxicity StudyNo drug interventionstreatmentNot Availablecompleted
NCT00473577
Study of the Tolerability, Safety, and Pharmacokinetics of CRA-024781 in Cancer Patientstreatment1completed
NCT01482377
A Study of RO5479599 Alone or in Combination With Cetuximab or Erlotinib in Participants With Metastatic and/or Locally Advanced Malignant Human Epidermal Growth Factor Receptor (HER3) Expressing Solid Tumors of Epithelial Cell Origintreatment1completed
NCT03077477
Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy VolunteersNo drug interventionstreatment1withdrawn
NCT02168777
Refametinib (BAY86-9766) in Combination With Regorafenib (Stivarga, BAY73-4506) in Patients With Advanced or Metastatic Cancertreatment1terminated
NCT00207077
Study of Cetuximab in Combination With Tarceva in Patients With Solid Tumorstreatment1completed
NCT06077877
A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumorstreatment1 / 2recruiting
NCT06444477
Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With CancerNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00195247
Study Evaluating TTI-237 in Advanced Malignant Solid Tumorstreatment1terminated
NCT03220347
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CC-90010 in Subjects With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin's Lymphomastreatment1active_not_recruiting
NCT00088647
Study Evaluating MST-997 in Advanced Malignant Solid Tumorstreatment1terminated
NCT04456647
Parenteral Nutrition Therapy in Patients With Incurable CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05574647
Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT00169845
Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer PatientsNo drug interventionsprevention3completed
NCT02690545
Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHLNo drug interventionstreatment1 / 2recruiting
NCT05902845
RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBLNo drug interventionstreatment0recruiting
NCT03604445
This Study Aims to Find and Test a Safe Dose of BI 905677 in Patients With Different Types of Cancer (Solid Tumours)No drug interventionstreatment1terminated
NCT01018745
Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in Japantreatment1completed
NCT01862198
The Usefulness of Endoscopic Ultrasound-guided Biliary Drainage With a Newly Designed Hybrid Metallic StentNo drug interventionstreatment4completed
NCT03433898
This Study Aims to Find a Safe and Effective Dose of BI 754091. The Study Also Aims to Find Safe and Effective Doses of BI 754091 and BI 754111 in Combination. This Study is Done in Asian Patients With Different Types of Cancertreatment0completed
NCT04518098
STABLE (Strength Training and Balance Leg Exercise) StudyNo drug interventionspreventionNot Availablerecruiting
NCT03554005
Extended Administration of Polyethylene Glycol (PEG) Interferon Alfa-2b in Participants With Solid Tumors (C/I97-349/MK-4031-009)treatment1completed
NCT02129205
A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid TumorsNo drug interventionstreatment1terminated
NCT00677105
A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma.treatment1completed
NCT03650205
Ivabradine to Prevent Anthracycline-induced CardiotoxicitypreventionNot Availableunknown_status
NCT03336905
Implementation of a Program Based on Adapted Physical Activity and Recommendations for Second Cancers Prevention for TYACsNo drug interventionspreventionNot Availablecompleted
NCT03814005
A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problemsother1completed
NCT02760797
A Study of Emactuzumab and RO7009789 Administered in Combination in Participants With Advanced Solid Tumorstreatment1completed
NCT05017597
Online Cancer-Related Fatigue ManagementNo drug interventionssupportive_careNot Availablewithdrawn
NCT02134197
Dose-escalation Study of Lupartumab Amadotin (BAY1129980)No drug interventionstreatment1terminated
NCT02961283
Study of ASN003 in Subjects With Advanced Solid TumorsNo drug interventionstreatment1terminated
NCT03138083
OMO-1 in Solid Malignanciestreatment1 / 2terminated
NCT05280483
ABSK021 Food Effect Study in Healthy Subjectsother1completed
NCT06341283
A Retrospective Real-world Study of Abemaciclib in HR+ Breast CancerNot AvailableNot Availablenot_yet_recruiting
NCT01086683
Rehabilitation of Cancer Survivors in Denmark: The Effect of a Psychosocial Rehabilitation CourseNo drug interventionssupportive_care2 / 3completed
NCT00969761
BI 6727 (Volasertib) in Combination With Cisplatin or Carboplatin in Patients With Advanced or Metastatic Solid Tumourtreatment1completed
NCT00547261
Phase I Dose Finding Study of SSR97225 Given in Patients With Refractory CancerNo drug interventionstreatment1terminated
NCT00400361
A Multiple Ascending Dose Study of R1507 in Patients With Advanced Solid Tumors.treatment1completed
NCT02479061
An Observational Study of the Prevalence of Patients Requiring Palliative Care in French Anti-cancer Centers.No drug interventionsNot AvailableNot Availablecompleted
NCT01049061
A Study of MORAb-003 in Patients With Solid Tumortreatment1completed
NCT03614728
Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)treatment1 / 2terminated
NCT01764828
BAY86-9766 Plus Gemcitabine Phase I Study in Asianother1completed
NCT05898828
Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal Cancertreatment1 / 2withdrawn
NCT00042328
A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patientstreatment2completed
NCT03210428
Quantitative MR Imaging in Locally Advanced Cervical CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT02171728
Dose Escalation Study of Continuous Once-daily Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumorstreatment1completed
NCT02530411
Fulvestrant +/- Vandetanib in Advanced Aromatase Inhibitor Resistant Breast Cancertreatment2unknown_status
NCT00421811
A Study of ADH-1 in Combination With Normothermic Isolated Limb Infusion of Melphalantreatment1 / 2completed
NCT03190811
Anti-PD-1 Alone or Combined With Autologous DC-CIK Cell Therapy in Advanced Solid TumorsNo drug interventionstreatment1 / 2completed
NCT01728311
Open Label Study of BAY1082439 in Patients With Advanced CancerNo drug interventionstreatment1completed
NCT00687011
Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)prevention4completed
NCT01561911
A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer TreatmentNo drug interventionsNot Available1completed
NCT00194493
Computerized Assessment for Patients With CancerNo drug interventionstreatment3completed
NCT01837693
Cervical Cancer Prevention: From DNA to mRNA? - New Technologies for Cervical Cancer Screening 2No drug interventionsscreeningNot Availableunknown_status
NCT05147493
A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairmenttreatment2not_yet_recruiting
NCT00594971
A Shared Care Approach for Seriously Ill Cancer Patients Between General Practice, Discharge Department and a Specialist Palliative Care TeamNo drug interventionshealth_services_researchNot Availablewithdrawn
NCT06496971
A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patientstreatment3not_yet_recruiting
NCT04556071
Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancertreatment2unknown_status
NCT03391778
Adoptive Cell Therapy Long-term Follow-up (LTFU) StudyNo drug interventionsother1recruiting
NCT03872778
[177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-NeoB Lesion Uptaketreatment1 / 2recruiting
NCT01964378
CORAL - Cebranopadol Versus Morphine Prolonged-release in Patients With Chronic Moderate to Severe Pain Related to Cancertreatment3terminated
NCT02798978
A Phase I, 2-part (Part 1 Being a Single Dose Escalation and Part 2, a Parallel Group) Study of Toll-like Receptor (TLR4) Agonist (GSK1795091) in Healthy SubjectsNo drug interventionstreatment1completed
NCT00625378
Sorafenib Long Term Extension Programtreatment3completed
NCT03911388
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumorstreatment1active_not_recruiting
NCT02273388
BI 6727 Administered Intravenously Every 3 Weeks in Patients With Solid Tumourstreatment1completed
NCT03085888
The STRIVE Study: Development of a Blood Test for Early Detection of Multiple Cancer TypesNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01120288
A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults With Advanced Solid Tumors With Liver MetastasesNo drug interventionstreatment1completed
NCT00067288
Meaning-Centered Psychotherapy in Advanced CancerNo drug interventionseducational_counseling_training2completed
NCT05878288
Deep sequencIng in Cutaneous Squamous CEll caRciNomasother2active_not_recruiting
NCT03712488
Differential Expression of CD200 in B-chronic Lymphoproliferative Disorders by Multicolour Flow CytometryNo drug interventionsNot AvailableNot Availableunknown_status
NCT04831307
68Ga-HTK03149 for Use as a Diagnostic RadiopharmaceuticalNo drug interventionsotherNot Availableunknown_status
NCT04711109
Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutationprevention3recruiting
NCT02585609
Sleep Quality in Patients With Advanced CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04526509
Master Protocol to Assess Safety and Dose of First Time in Human Next Generation Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Advanced Solid Tumorstreatment1terminated
NCT02001909
Effect of Neomycin on the Pharmacokinetics of RegorafenibNot Available1completed
NCT00748709
Phase II Trial of BIBW 2992 (Afatinib) in Genetically Pre-screened Cancers With EGFR and/or HER2 Gene Amplification.treatment2terminated
NCT00102609
A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue Sarcomatreatment1completed
NCT05745909
Trial Comparing Loop Ileostomy Versus Loop Transverse ColostomyNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT01774409
Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT02043756
Phase I and Pharmacokinetic Study of Mitoxantrone Hydrochloride Liposome Injectiontreatment1completed
NCT03389256
Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLCtreatment2unknown_status
NCT02871856
International Lung Screen Trial (ILST)No drug interventionsscreeningNot Availableactive_not_recruiting
NCT00091585
Initial Safety Assessment of SNS-595 for the Treatment of Solid Tumors.treatment1completed
NCT06170385
Pediatric Early Rehabilitation in Acute Lymphoblastic LeukemiaNo drug interventionssupportive_careNot Availablerecruiting
NCT00147485
A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced Cancertreatment1terminated
NCT02592785
Phase I Dose Escalation Study of BAY 1163877 (Rogaratinib) in Japanese Subjects With Refractory, Locally Advanced or Metastatic Solid TumorsNo drug interventionstreatment1completed
NCT03307785
Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042treatment1active_not_recruiting
NCT01026415
Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35)treatment1completed
NCT02548715
Levothyroxine Treatment for Subclinical Hypothyroidism After Head and Neck Surgerytreatment2 / 3withdrawn
NCT06247215
Development of a Culturally Tailored Resilience-building Intervention for Chinese American's Advance Care Planning DiscussionsNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT01968915
Safety and Tolerability of Oral LCL161 in Japanese Adult Patients With Advanced Solid Tumorstreatment1completed
NCT02254915
SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study INo drug interventionstreatment3withdrawn
NCT01151215
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancertreatment2terminated
NCT05131815
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer SurvivorsNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT00573937
Methadone Versus Morphine for Cancer-Related Paintreatment2terminated
NCT02171637
Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumorstreatment1completed
NCT04133337
Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLCtreatment1 / 2unknown_status
NCT00078637
Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphomatreatment1completed
NCT01538537
Safety of ON 01910.Na as a 3-day Infusion in Patients With Advanced Cancertreatment1completed
NCT01460537
Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor Copanlisib With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancertreatment1completed
NCT03250832
Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumorstreatment1completed
NCT04493632
OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.No drug interventionsNot AvailableNot Availablerecruiting
NCT04996732
Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Single-institutional Cancer RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT02031432
CORAL XT - Open-label Extension Trial of the CORAL Trialtreatment3completed
NCT00087932
Socioeconomic Influences on Complementary and Alternative Medicine Use in Cancer TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT00726752
A Study In Patients With Advanced Solid Tumortreatment1completed
NCT02223052
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignanciestreatment1completed
NCT02674152
Dose Finding Study of BI 836880 in Patients With Solid Tumorstreatment1completed
NCT01188252
Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 Given in a 3 Days on / 4 Days Off Schedule in Subjects With Advanced Malignanciestreatment1completed
NCT04039100
Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological DiseaseNo drug interventionssupportive_careNot Availablecompleted
NCT02490800
Phase 1/2a Study of Oral BAL101553 in Adult Patients With Solid Tumors or Glioblastoma or High-grade Gliomatreatment1 / 2completed
NCT00095459
BAY 43-9006 (Sorafenib) and Bevacizumab (Avastin) To Treat Solid Tumorstreatment1completed
NCT03843359
A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumorstreatment1active_not_recruiting
NCT05755659
Clinical on the Safety and Efficacy of Fosaprepitant Dimeglumine for Injection in the Prevention of CINV.preventionNot Availablerecruiting
NCT02211859
Dose Escalation Study of BI 2536 BS in Patients With Advanced Solid Tumours With Repeated Administration in Patients With Clinical Benefittreatment1completed
NCT00481559
Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate ToxicityNot AvailableNot Availableapproved_for_marketing
NCT01169675
BIBW 2992 (Afatinib) in Combination With Pemetrexed in Advanced Solid Tumourstreatment1completed
NCT05581875
A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractorytreatment1 / 2not_yet_recruiting
NCT00424775
A Study of Carboplatin + Paclitaxel and MK0683 in Patients With Chemotherapy-naive Non-Small Cell Lung Cancer (NSCLC)(0683-066)treatment1terminated
NCT02330575
Alberta Cancer Exercise Pilot Randomized TrialNo drug interventionstreatmentNot Availablecompleted
NCT06329570
Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)treatment1 / 2not_yet_recruiting
NCT05537870
The Effectiveness of Nurse Navigators in Cancer CareNo drug interventionstreatmentNot Availablecompleted
NCT01585870
Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of Sorafenib and Eribulin in Combinationtreatment1completed
NCT03308942
Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participantstreatment2completed
NCT06551142
A Study of GSK5764227 in Participants With Advanced Solid Tumorstreatment1not_yet_recruiting
NCT01995942
Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) TrialNo drug interventionsNot AvailableNot Availableunknown_status
NCT02696642
Phase I Study of Anetumab Ravtansine in Hepatic or Renal Impairmenttreatment1completed
NCT04673942
A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid TumorsNo drug interventionstreatment2recruiting
NCT02775799
National Swiss Sarcoma Cohort StudyNo drug interventionsNot AvailableNot Availableterminated
NCT05993299
Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcomatreatment2active_not_recruiting
NCT03709706
Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumabtreatment1 / 2terminated
NCT00574106
A Study to Evaluate the Effect of Far Infrared Radiation for Cancer TreatmentNo drug interventionstreatment1unknown_status
NCT00359606
5-Fluoro-2'-Deoxcyctidine and Tetrahydrouridine to Treat Patients With Advanced Cancertreatment1completed
NCT00099606
Phase I (PH I) Mad Refractory Solid Tumor Studytreatment1completed
NCT01688206
A Study of Vanucizumab (RO5520985) Alone or in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumorstreatment1completed
NCT05475106
Pilot Study of Neoantigen Peptides and Leukine for the Treatment of NeoplasmsNo drug interventionstreatment0recruiting
NCT04141449
A Multilevel Intervention to Improve Timely Cancer Detection and Treatment InitiationNo drug interventionshealth_services_research2recruiting
NCT00398749
Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2)Not AvailableNot Availablecompleted
NCT06035549
Resilience in East Asian Immigrants for Advance Care Planning DiscussionsNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT02629549
Intraoperative Imaging of Pituitary Adenomas by OTLdiagnostic1terminated
NCT04449549
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxeltreatment2recruiting
NCT00511849
Study Of SU011248 In Combination With Paclitaxel/Carboplatin In Patients With Advanced Solid Tumorstreatment1completed
NCT04704349
Latest Imaging SPECT System Evaluation Phase 1No drug interventionsotherNot Availablecompleted
NCT01911936
A Phase I Study of LJM716 in Japanese Patients With Advanced Solid TumorsNo drug interventionstreatment1completed
NCT02265536
A Study of LY3022855 In Participants With Breast or Prostate CancerNo drug interventionsbasic_science1completed
NCT00448136
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract.treatment2completed
NCT03666936
Facilitate the Return to Work of Cancer SurvivorsNo drug interventionstreatmentNot Availablecompleted
NCT03803436
Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver TransplantationNo drug interventionstreatment2recruiting
NCT04618913
Anticoagulation in Patients With Venous Thromboembolism and CancerNot AvailableNot Availableactive_not_recruiting
NCT01043913
Guarana (Paullinia Cupana) for Breast Cancer Chemotherapy-related FatigueNo drug interventionstreatment2completed
NCT00117013
A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1atreatment1completed
NCT01944813
Advance Care Planning: A Way to Improve End-of-life Care Life CareNo drug interventionssupportive_careNot Availableunknown_status
NCT00735813
Taurolidine Lock Solution in the Prevention of Catheter Related BacteremiaNo drug interventionsprevention3completed
NCT03441113
Extended Access of Momelotinib in Adults With Myelofibrosistreatment2active_not_recruiting
NCT02964013
Study of Vibostolimab Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001) ( KEYVIBE-001)treatment1completed
NCT03926013
A Study of JNJ-63898081 in Participants With Advanced Stage Solid TumorsNo drug interventionstreatment1completed
NCT03968718
PATIENT VOICES Integration of Systematic Assessment of Patient Reported Outcomes Within Clinical Oncology PracticeNo drug interventionshealth_services_researchNot Availableunknown_status
NCT02416518
Genetic Exploration of the Molecular Basis of Malignancy in AdultsNo drug interventionsNot AvailableNot Availablecompleted
NCT05519618
Multi-modality Evaluation of Flow Rate, Pressure and Size of Spine Epidural Venous PlexusNo drug interventionsNot AvailableNot Availableunknown_status
NCT04456218
Clinical Evaluation of a Custom-made and Disposable Endoscope System for Biliary TractNo drug interventionsdiagnosticNot Availablecompleted
NCT02485119
Phase I Dose Escalation Study of BAY94-9343 Given by Intravenous Infusion Every 3 Weeks in Japanese Subjects With Advanced Malignanciestreatment1completed
NCT02602119
Intraoperative Imaging of Pulmonary Nodules by OTL38diagnostic1completed
NCT00528619
A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumorstreatment1completed
NCT02171741
Dose Escalation Trial of BIBW 2992 Administration in Combination With Docetaxel in Patients With Advanced Solid Tumorstreatment1completed
NCT03961841
Perioperative Combination Chemotherapy Versus Chemoradiation for Locally Advanced EGJ AdenocarcinomaNo drug interventionstreatment3not_yet_recruiting
NCT02192541
Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomastreatment1terminated
NCT06044441
Evaluation and Implementation Preparation of a Proactive Palliative Care Model (ENABLE-SG)No drug interventionshealth_services_researchNot Availablerecruiting
NCT02091141
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumorstreatment2completed
NCT02717741
A Study of Tafetinib in Chinese Patients With Advanced Solid TumorNo drug interventionsNot Available1unknown_status
NCT02899117
Yoga Intervention to Improve Pediatric Cancer Patients' Sleep & Life Quality and Parents' Well-BeingNo drug interventionssupportive_careNot Availablecompleted
NCT04932317
Oral Symptom Assessment Scale (OSAS): Validity and ReliabilityNo drug interventionsNot AvailableNot Availablecompleted
NCT00716417
Study to Determine the Maximum Tolerated Dose of BIBW 2992 (Afatinib) When Combined With Cisplatin/Paclitaxel or Cisplatin/5-FU in Patients With Advanced Solid Tumourstreatment1completed
NCT02487017
DC-CIK Combined With TACE in the Treatment of Hepatocellular CarcinomaNo drug interventionstreatment2unknown_status
NCT00266617
A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in Patients With Anemia as a Result of Advanced Cancer and Treatment With Aggressive Chemotherapytreatment2completed
NCT05391217
Feasibility of Remote Activity Assessment and PRO Collection Among Transgender Cancer SurvivorsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04204434
Biomarkers For Immune Checkpoint InhibitorsNo drug interventionsNot AvailableNot Availablecompleted
NCT04147234
A Study to Find the Best Dose of BI 1387446 Alone or in Combination With Ezabenlimab (BI 754091) in Patients With Different Types of Advanced or Metastatic Cancer (Solid Tumors)treatment1completed
NCT00040534
Safety and Tolerability Study of Farnesyl Protein Transferase Inhibitor in Combination With Gemcitabine and Cisplatin in Advanced Cancer (Study P01499)(TERMINATED)No drug interventionstreatment1terminated
NCT00490334
Assessment and Rehabilitation of Cognitive Impairments in Pediatric Survivors of CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00065234
Acupuncture to Prevent Postoperative Bowel Paralysis (Paralytic Ileus)No drug interventionsprevention2terminated
NCT00443534
A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.treatmentNot Availablecompleted
NCT02972034
Study of MK-8353 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Malignancies (MK-8353-013)treatment1completed
NCT02567734
Clinical Trials of CT-guided Percutaneous Irreversible Electroporation(IRE)in the Treatment of Patients With Locally Advanced TumorsNo drug interventionstreatmentNot Availableunknown_status
NCT04442724
Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapyNo drug interventionstreatmentNot Availablerecruiting
NCT03697824
Clinical Trial of Safety, Tolerability and Antitumor Activity of Genetically Engineered T Cells in Combination With Anti-Cancer Agents in Relapsed and Refractory Synovial Sarcoma Expressing New York Esophageal Antigen-1 (NY-ESO-1) and/or LAGE-1atreatment2withdrawn
NCT00674024
Pazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver Functiontreatment1completed
NCT00701324
BI 811283 in Various Solid TumoursNo drug interventionstreatment1completed
NCT02219724
A Study to Assess Safety and Pharmacokinetics of MOXR0916 in Participants With Locally Advanced or Metastatic Solid Tumorstreatment1completed
NCT02960724
uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal CancerNo drug interventionsdiagnostic2unknown_status
NCT03208816
Community-Led Action Research in Oncology: Improving Symptom ManagementNo drug interventionssupportive_careNot Availablecompleted
NCT00898716
Multiple Ascending Dose Study of BMS-754807 in Patients With Solid Tumors in Japantreatment1completed
NCT04446416
Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM PatientstreatmentNot Availablecompleted
NCT03416816
A Study of DSP-0337 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic ProfileNo drug interventionstreatment1terminated
NCT03384316
Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancertreatment1completed
NCT01214616
BIBW 2992 (Afatinib) and Vinorelbine in Japanese Patients With Advanced Solid Tumourstreatment1completed
NCT03366116
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid TumorsNo drug interventionstreatment1recruiting
NCT02192216
The Effect of Resistance Training and Aerobic Training on Body Composition During ChemotherapyNo drug interventionssupportive_careNot Availableterminated
NCT05836896
A Phase I Trial to Establish the Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting Chimeric Antigen Receptor (CAR) T-cells in Patients With Relapsed and Refractory B-cell MalignanciesNo drug interventionstreatment1recruiting
NCT00998296
Phase I Dose Escalation Study of Concomitant BIBF 1120 and BIBW 2992 in Patients With Advanced Solid Tumours.treatment1completed
NCT01346358
A Study of IMC-CS4 in Subjects With Advanced Solid TumorsNo drug interventionstreatment1completed
NCT03948958
PREMO Study: to Investigate Port REMoval OutcomesNo drug interventionspreventionNot Availablecompleted
NCT05919758
Value of Right-sided Hemicolectomy for Chldren With High-risk Neuroendocrine Tumors of the AppendixNo drug interventionsNot AvailableNot Availablerecruiting
NCT01003158
Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients.treatment1completed
NCT02494258
A Study to Evaluate Long-term Safety of CC-486 (Oral Azacitidine) in Subjects With Hematological Disorderstreatment2active_not_recruiting
NCT06161558
Erlotinib in Combination With Select Tyrosine Kinase Inhibitors in Adult Patients With Advanced Solid Tumorstreatment1not_yet_recruiting
NCT04604158
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT02110758
Evaluating the Impact of Patient-Centered Oncology CareNo drug interventionsNot AvailableNot Availablecompleted
NCT01023958
Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancertreatment2completed
NCT01974258
Safety, Tolerability, and Pharmacokinetics of Onartuzumab Combined With Vemurafenib and/or Cobimetinib in Cancer Patientstreatment1withdrawn
NCT04763135
Mirtazapine in Cancer-related Poly-symptomatologytreatment3terminated
NCT05602935
Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Studytreatment2active_not_recruiting
NCT05827835
CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic DiseasesNo drug interventionstreatment2recruiting
NCT02129335
Stress, Exercise Behavior and Survival in Patients With Newly Diagnosed Glioblastoma and in a Close PartnerNo drug interventionsNot AvailableNot Availableterminated
NCT03416335
A Study of DSP-0509 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profiletreatment1 / 2terminated
NCT00684463
Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)prevention4completed
NCT01772563
Investigation of Potential Drug-drug Interaction of Volasertib With Itraconazole in Patients With Various Tumourstreatment1completed
NCT02644863
Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancertreatment2unknown_status
NCT00960063
A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)treatment1terminated
NCT00055263
A New Formulation of Calcitriol (DN-101) in Patients With Advanced Malignanciestreatment1completed
NCT04350463
A Safety and Efficacy Study of CC-90011 in Combination With Nivolumab in Subjects With Advanced Cancerstreatment2completed
NCT01538563
Safety of 24-Hour Infusion of ON 01910.Na in Patients With Advanced Cancertreatment1completed
NCT02429063
Light Therapy to Increase Energy in Adolescents and Young Adults Newly Diagnosed With Solid Tumors: A Pilot StudyNo drug interventionssupportive_careNot Availablecompleted
NCT04151186
A Clinical Study on the Safety and Efficacy of CAR-T Therapy for the TM4SF1- and EpCAM-positive Solid TumorsNo drug interventionstreatmentNot Availableunknown_status
NCT03072186
Proposal for Intraoperative Administration of Intravenous Indocyanine Green to Evaluate Position of the Optic Canal, Position of the Internal Carotid Arteries, Tumor Vascularization, and Vessel Encasement in Endoscopic Endonasal Cranial Base SurgeryNo drug interventionsdiagnosticNot Availablecompleted
NCT01309386
A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese Participantstreatment3completed
NCT02221986
Interdisciplinary Rehabilitation of Patients With Glioma During Anti-cancer TreatmentNo drug interventionstreatmentNot Availablecompleted
NCT00862186
Self-Management of Cancer-Related Fatigue by AdolescentsNo drug interventionssupportive_careNot Availablecompleted
NCT00425139
Evaluation of a Video Game for Adolescents and Young Adults With CancerNo drug interventionssupportive_careNot Availablecompleted
NCT01813539
A Study of ARGX-110 in Participants With Advanced Malignanciestreatment1 / 2completed
NCT04958239
A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancertreatment1recruiting
NCT00117039
A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemiatreatment4completed
NCT05066139
Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G)No drug interventionssupportive_careNot Availablerecruiting
NCT00590239
Barrett's Esophagus Related Neoplasia (BERN) ProjectNo drug interventionsNot AvailableNot Availablerecruiting
NCT00740922
Evaluation of the Safety Follow-up of Becaplermin or Placebo Gel Following Treatment of Chronic, Full Thickness Diabetic UlcersNo drug interventionsNot AvailableNot Availablecompleted
NCT02222922
A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumorstreatment1completed
NCT01303822
Mindfulness-based Stress Reduction in Cancer TreatmentNo drug interventionstreatmentNot Availablecompleted
NCT01868022
Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signalingtreatment1completed
NCT05374122
AI Guidance for Biopsy in Suspected CholangiocarcinomaNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT06177925
A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLCtreatment2recruiting
NCT04442425
Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor PainNo drug interventionsNot AvailableNot Availablecompleted
NCT01722825
Study of LY2157299 in Japanese Participants With Cancertreatment1completed
NCT01096030
Phase I Study of BAY73-4506 in Chinese Patients With Advanced, Refractory Solid Tumorstreatment1completed
NCT05187130
The Effect of Mindfulnes Program on Stress, Depression and Psychological Well-being in Cancer PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT00578630
Interindividual Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Bone Marrow Transplantation PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00349830
Novel Serum Markers for Monitoring Response to Anti-Cancer TherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00124930
Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancertreatment3terminated
NCT02632448
A Study of LY2880070 in Participants With Advanced or Metastatic Cancerbasic_science1 / 2recruiting
NCT00607048
Dose Finding Study Of CP-870,893, An Immune System Stimulating Antibody, In Combination With Paclitaxel And Carboplatin For Patients With Metastatic Solid Tumorstreatment1completed
NCT00024648
Study to Determine Maximum Tolerated Dose of LErafAON Combined With Radiotherapy in Patients With Advanced Malignanciestreatment1completed
NCT03402048
The EPIC Trial The Elderly Patient Individualized Chemotherapy Trialtreatment3unknown_status
NCT02909348
Immunophenotyping of Melanoma Patients on Treatment With PembrolizumabNot AvailableNot Availablecompleted
NCT01725048
Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With Cancersupportive_care0completed
NCT02952248
A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumourstreatment1completed
NCT01688557
Trial on Innovative Technologies in ColonoscopyNo drug interventionsdiagnosticNot Availablecompleted
NCT02859857
Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumorstreatment1completed
NCT02806557
Profiling Neutrophil Counts in Patients on ChemotherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT04194957
Improving the Safety of Fluoropyrimidine-based ChemotherapytreatmentNot Availableunknown_status
NCT01795157
Computer Based Assessment and TreatmentNo drug interventionsdiagnosticNot Availablecompleted
NCT00773526
A Dose-Escalation Study of RO5126766 in Patients With Advanced Solid Tumors.treatment1completed
NCT02587026
Biorepository for Precision GenomicsNo drug interventionsNot AvailableNot Availableterminated
NCT04462926
Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly DiagnosedNo drug interventionsdiagnosticNot Availablerecruiting
NCT00399126
Phase I Trial of Paclitaxel With Perifosinetreatment1completed
NCT05592626
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsNo drug interventionstreatment1 / 2recruiting
NCT00237926
Comparing Aerobic to Resistance Training in Recovery From CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00721266
A Dose-Escalation Study of RO5083945 in Patients With Metastatic and/or Locally Advanced Malignant Epidermal Growth Factor Receptor (EGFR)+ Solid Tumors.treatment1completed
NCT06004466
Noninvasive Internal Jugular Venous OximetryNo drug interventionsNot AvailableNot Availablerecruiting
NCT06365866
Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.No drug interventionstreatmentNot Availablerecruiting
NCT03954366
Drug-Drug Interaction Study of Rucaparib, Rosuvastatin and Oral Contraceptivesother1completed
NCT02315066
Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566treatment1completed
NCT01403974
Phase I Trial of BI 836845 for Various Solid CancerNo drug interventionstreatment1completed
NCT03099174
This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancertreatment1completed
NCT02133274
A Psychosocial Intervention Plus Early Palliative Care in the Reduction of Depression of Advanced Cancer PatientsNo drug interventionssupportive_careNot Availableterminated
NCT00985374
A Multiple Ascending Dose Study of the mTOR Inhibitor (RAD001) in Combination With R1507 in Patients With Advanced Solid Tumorstreatment1terminated
NCT02437474
Impact of Elimination or Reduction of Dietary Animal Proteins on Cancer Progression and Survival - A Pilot StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00024674
Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 Daystreatment1withdrawn
NCT04318574
The Effects of a 6-week Balance, Agility, Strengthening Exercise ClassNo drug interventionstreatmentNot Availableunknown_status
NCT06203574
Clinical Study of TROP-2 PET/CT for Noninvasive Diagnosis of Solid TumorsNo drug interventionsdiagnosticNot Availablerecruiting
NCT01317420
Trial to Determine MTD of BI 836845 Administered Intravenously Once Every Three Weeks in Patients With Advanced Solid Tumours and Later a Weekly Dosing Schedule in Selected Tumour TypesNo drug interventionstreatment1completed
NCT06237920
Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimabtreatment2recruiting
NCT02622620
Study on Neuroepithelial Tumor Grading and Pseudoprogression After Glioma Therapy Using Advanced Functional MRI TechniquesNo drug interventionsNot AvailableNot Availableunknown_status
NCT00377520
A Trial for Patients With Advanced/Recurrent Endometrial Cancertreatment2completed
NCT00032682
Constipation in Pediatric Cancer Patients Receiving Vinca Alkaloids or NarcoticsNo drug interventionsNot AvailableNot Availablecompleted
NCT04008082
A Study of Overall Survival in Participants With Unresectable Hepatocellular CarcinomaNot AvailableNot Availablecompleted
NCT03757182
Digitally-Captured Step Counts for Evaluating Performance Status in Advanced Cancer PatientsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00378482
A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued.treatment2completed
NCT00097682
Views of Cancer Patients Regarding Financial Conflicts of InterestNo drug interventionsNot AvailableNot Availablecompleted
NCT02221882
A Study of LY3164530 in Participants With CancerNo drug interventionstreatment1completed
NCT00041782
Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patientstreatment2terminated
NCT03166631
A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spreadtreatment1terminated
NCT02659631
PF-06671008 Dose Escalation Study in Advanced Solid TumorsNo drug interventionstreatment1terminated
NCT02403531
Induction Chemotherapy Followed by Chemoradiotherapy in Esophageal Cancertreatment2completed
NCT03469531
Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancertreatment2unknown_status
NCT05241873
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutationstreatment1 / 2active_not_recruiting
NCT00030173
A Trial to Evaluate Epothilone D in Patients With Advanced Solid Tumorstreatment1completed
NCT06236373
The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio EmiliaNo drug interventionsNot AvailableNot Availablerecruiting
NCT04179773
Chemotherapy and Liver Cirrhosis in Frequently-associated CancersNo drug interventionsNot AvailableNot Availablerecruiting
NCT00900627
Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II)treatment1 / 2completed
NCT00050427
A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancertreatment2completed
NCT00047476
D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patientstreatment2completed
NCT02257476
Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumorstreatment1completed
NCT02581176
Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Studytreatment4completed
NCT03270176
A Dose-Finding Study of the Second Mitochondrial Activator of Caspases (SMAC) Mimetic Debio 1143 When Given in Combination With Avelumab to Participants With Advanced Solid Malignancies and to Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Platinum-Based Therapytreatment1completed
NCT00390676
A Study of ADH 1 in Combination With Carboplatin, or Docetaxel or Capecitabinetreatment1completed
NCT01915576
Phase I Dose Escalation Study With an Allosteric AKT 1/2 Inhibitor in PatientsNo drug interventionstreatment1completed
NCT05615376
Beat to Beat A Study in Paediatric, Adolescent and Young Adult Patients Who Are Undergoing or Have Undergone Cancer Therapy to Evaluate the Agreement Between QTc Measured Using 12 Lead Electrocardiogram (ECG) and a Wearable Device ECGNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT04397276
A Study of JNJ-70218902 in Participants With Advanced Stage Solid TumorsNo drug interventionstreatment1active_not_recruiting
NCT01971476
Open Dose Escalating Trial to Determine the Maximum Tolerated Dose in Paediatric Patients With Advanced Cancers for Whom no Therapy is Knowntreatment1completed
NCT03744676
A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)treatment2completed
NCT04627376
Multimodal Program for Cancer Related Cachexia PreventionNo drug interventionspreventionNot Availablerecruiting
NCT00195260
Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumorstreatment1completed
NCT04724460
Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With CancerNo drug interventionstreatment4active_not_recruiting
NCT05343260
Impact of Anesthesia Maintenance Methods on 5-year Survival After SurgerypreventionNot Availableunknown_status
NCT01815294
A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancertreatment1completed
NCT01279291
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancertreatment1terminated
NCT00384891
Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder CancerNo drug interventionstreatment3terminated
NCT01394991
A Safety Study of Epoetin Alfa in Patients With Cancer Who Have Chemotherapy-Related Anemiatreatment4completed
NCT05912062
Early On-treatment Transcriptional Profiling as Predictor of Response in Early-stage HER2-positive Breast CancerNot AvailableNot Availablerecruiting
NCT00099762
Catheterization to Locate Mesenchymal Tumors in Patients With Tumor-Induced Osteomalacia or Oncogenic OsteomalaciaNo drug interventionsNot AvailableNot Availablecompleted
NCT03434262
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumorstreatment1completed
NCT04862780
(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLCtreatment1 / 2active_not_recruiting
NCT01234480
Intended Use Study of the BD SurePath Plus™ PapNo drug interventionsdiagnosticNot Availableterminated
NCT02491580
Post-transplant Cancer Incidence and Survival in Patients With or Without Pre-transplant CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT06175780
Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid TumorsNo drug interventionstreatment1recruiting
NCT02369029
BAY1238097, First in ManNo drug interventionstreatment1terminated
NCT05830929
Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female Cancer PatientsNo drug interventionsotherNot Availablerecruiting
NCT06285929
ACS Community Access to Resources Education and SupportNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT00001189
The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue TumorsNo drug interventionstreatment2completed
NCT03336489
Evaluation of the Organization of Continuity of Care for Home Hospice Patients by Four Parisian Health NetworksNo drug interventionsNot AvailableNot Availablecompleted
NCT00389389
Phase I, Open-Label, Dose-Escalation Study of AZD4877 in Solid TumorsNo drug interventionstreatment1completed
NCT02657889
Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancertreatment1 / 2completed
NCT01288989
A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid TumorsNo drug interventionstreatment1completed
NCT00341692
Studying Normal Breast Tissue and Cancer RiskNo drug interventionsNot AvailableNot Availablecompleted
NCT04310592
Natural Killer Cell (CYNK-001) Infusions in Adults With AMLtreatment1recruiting
NCT00989092
Darbepoetin Alfa and Anemia of Cancersupportive_care2terminated
NCT02092792
A Study Evaluating the Safety of Escalating Doses of DLYE5953A in Patients With Refractory Solid TumorsNo drug interventionstreatment1completed
NCT01618344
Smart-phone Application to Promote Medication Adherence in Adolescents and Young Adults (AYA) With CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02042144
Safety and Effectiveness of RegorafenibNot AvailableNot Availablecompleted
NCT05514444
Study of MK-4464 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors (MK-4464-001)treatment1active_not_recruiting
NCT04192344
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumortreatment1recruiting
NCT02825940
A Study to Assess the Pharmacokinetics, Efficacy, and Safety of Atezolizumab Administered Intravenously (IV) as a Single Agent or in Combination With Chemotherapy in Chinese Participants With Locally Advanced or Metastatic Solid Tumorstreatment1completed
NCT02558140
A Dose Escalation Study of RO6874813 in Participants With Locally Advanced or Metastatic Solid TumorsNo drug interventionstreatment1completed
NCT03037840
Detecting Tumor Specific Amplitude-modulated Frequencies of Cancer PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT01445340
Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell Lymphomatreatment1terminated
NCT02458040
Clinical Benefit of Genetic Biomarkers for Guiding Treatment Decisions in Oncology DrugsNo drug interventionsNot AvailableNot Availablewithdrawn
NCT06114940
Neoadjuvant Immune-based Combinations in Patients Undergoing Nephrectomy for Locally Advanced ccRCCtreatment2recruiting
NCT03782467
Phase 1 Study in Patients With Advanced and/or Refractory Solid Malignancies to Evaluate the Safety of ATOR-1015No drug interventionstreatment1completed
NCT04061967
SMS-based Summons in Cervical ScreeningNo drug interventionspreventionNot Availablerecruiting
NCT06234267
Eat, Play, Sleep: A Text Message Approach to Promoting Health Behaviors for Cancer Survivors and Their CaregiversNo drug interventionssupportive_careNot Availablerecruiting
NCT02739867
Tumor-educated Platelets in Venous ThromboembolismNo drug interventionsNot AvailableNot Availablecompleted
NCT00982267
A Trial Of SU14813 In Patients With Advanced Solid MalignanciesNo drug interventionstreatment1completed
NCT02688101
Dose-finding and Pharmacokinetic Study of DpC, Administered Orally to Patients With Advanced Solid Tumorstreatment1completed
NCT02516501
Impact of a Ketogenic Diet Intervention During Radiotherapy on Body CompositionNo drug interventionstreatmentNot Availablecompleted
NCT04448301
PC001- A Study to Evaluate the Usability of PointCheckNo drug interventionsdiagnosticNot Availablecompleted
NCT05887401
Physical Activity and Healthy Eating Among Young Adult Cancer SurvivorsNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT01291901
NP2 Enkephalin For Treatment of Intractable Cancer Paintreatment2completed
NCT00125801
The Pain Pen for Breakthrough Cancer Paintreatment3terminated
NCT03027401
Clinical Sequencing of Cancer and Tissue Repository: OncoGenomicsNo drug interventionsNot AvailableNot Availablewithdrawn
NCT01234701
Agreement Among Expert Radiologists in Diagnosing Primary Liver Tumors by Magnetic Resonance Imaging (MRI)No drug interventionsNot AvailableNot Availablecompleted
NCT00677001
A Research Study to Evaluate the Safety of R306465, a Drug in Development for Cancer and to Study the Absorption, Break Down and Elimination in Patients With Advanced Solid Malignancies.treatment1completed
NCT05964101
Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinomatreatment2recruiting
NCT02500004
Brown Adipose Tissue Activity and Energy Metabolism in CachexiaNo drug interventionsdiagnosticNot Availablecompleted
NCT02333604
Cancer Experience Registry (CER) for Cancer Patients and CaregiversNo drug interventionsNot AvailableNot Availablerecruiting
NCT00264472
A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid TumorsNo drug interventionstreatment1suspended
NCT04222972
A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)treatment3active_not_recruiting
NCT02211872
BI 2536 BS in Patients With Advanced Solid Tumours and Repeated Administration in Patients With Clinical Benefittreatment1completed
NCT00644072
SNX-5422 to Treat Solid Tumor Cancers and Lymphomastreatment1completed
NCT00100672
Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Cancertreatment1completed
NCT03493672
Counting Steps! Integration of Objectively Assessed Physical Activity and Fitness With Smartphones in Clinical Oncology Practice.No drug interventionsNot AvailableNot Availablecompleted
NCT03648372
A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune Systemtreatment1 / 2terminated
NCT02621268
Minimally Invasive Imagery With Indocyanine Greendiagnostic1completed
NCT01443468
Clinical and Genetic Studies of Li-Fraumeni SyndromeNo drug interventionsNot AvailableNot Availablerecruiting
NCT02170168
The Orkdal Model. Collaboration Between Specialist and Community Care Within Palliative Cancer CareNo drug interventionsNot AvailableNot Availablecompleted
NCT01962168
Evolution® Biliary Stent System Clinical StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00938769
Enhanced Self-Efficacy TrainingNo drug interventionshealth_services_researchNot Availablecompleted
NCT05816369
Oral Nutritional Supplement Preferences in Patients With CancerNo drug interventionssupportive_careNot Availablerecruiting
NCT04404569
Continued Treatment for Participants Enrolled in Studies of BXQ-350treatment1enrolling_by_invitation
NCT02459769
Exercise Intervention for LGBT Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT02765269
Intelligent Pain Management System for Assessing Pain in Cancer PatientsNo drug interventionshealth_services_researchNot Availablecompleted
NCT01586546
A Pilot Study To Assess Guidance in and Subsequent Use of Mind-Body Techniques on the Quality of Life of Cancer PatientsNo drug interventionssupportive_careNot Availableterminated
NCT00939146
Outlook: An Intervention to Improve Quality of Life in Serious IllnessNo drug interventionsNot AvailableNot Availablecompleted
NCT01853046
Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairmenttreatment1completed
NCT05797246
Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)treatment2recruiting
NCT02122146
A Study Of PF-06664178 In Patients With Advanced Solid TumorsNo drug interventionstreatment1terminated
NCT04811846
CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and BloodNo drug interventionstreatmentNot Availablerecruiting
NCT04697446
External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLCNo drug interventionsNot AvailableNot Availableunknown_status
NCT03693612
GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumorstreatment1 / 2completed
NCT02740712
Pharmacokinetic Drug-Drug Interaction Study of Rucaparibother1completed
NCT06149312
Feasibility of an Advance Care Planning InterventionNo drug interventionssupportive_careNot Availablerecruiting
NCT02410512
A Study to Assess the Safety and Pharmacokinetics of MOXR0916 and Atezolizumab (Also Known as MPDL3280A or Anti-PD-L1) in Participants With Locally Advanced or Metastatic Solid Tumorstreatment1completed
NCT00676910
A Research Study of JNJ-26854165 to Determine the Safety and Dose in Patients With Advanced Stage or Refractory Solid Tumors.treatment1completed
NCT03674710
A Multi-center, Prospective, Single-blind, Controlled Trial Comparing Diagnostic Value of Different EUS-FNA TechniquesNo drug interventionsdiagnosticNot Availableunknown_status
NCT01411410
Phase I Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With Paclitaxel in Patients With Advanced Cancertreatment1completed
NCT04146610
Study of DP303c Administered Intravenously to Subjects With HER2-Positive in Advanced Solid TumorsNo drug interventionstreatment1unknown_status
NCT01103310
Radiation Dosimetry, Metabolism, Pharmacokinetics, Safety and Tolerability and PET Imaging With BAY94-9392 in Healthy Volunteers and Patients With Cancer or InflammationNo drug interventionsdiagnostic1completed
NCT03739710
Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)treatment2recruiting
NCT02348710
Exercise Intervention for Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT00257881
Study Evaluating Intravenous CMD-193 in Subjects With Advanced Malignant Solid TumorsNo drug interventionstreatment1terminated
NCT00420381
Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancertreatment2completed
NCT02929381
Advanced Endoscopic Imaging in ColonoscopyNo drug interventionsdiagnosticNot Availableunknown_status
NCT03449381
This Study Aims to Find the Best Dose of BI 907828 (Brigimadlin) in Patients With Different Types of Advanced Cancer (Solid Tumors)treatment1recruiting
NCT01789281
Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.treatment4completed
NCT01179295
Japanese BAY86-9766 Monotherapy Phase I Studytreatment1completed
NCT02081495
A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancertreatment1completed
NCT00057395
A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignanciestreatment1 / 2unknown_status
NCT00065195
REST: Reducing End-of-Life Symptoms With TouchNo drug interventionstreatment2completed
NCT04537195
Effects of a Lay-led Anxiety and Depression Self-management Program for Cancer PatientsNo drug interventionstreatmentNot Availablerecruiting
NCT01811095
A Randomized Controlled Trial of a Robotic Simulation Curriculum to Teach Robotic SuturingNo drug interventionsNot AvailableNot Availablecompleted
NCT00050414
A Study of Trabectedin in Patients With Advanced Ovarian Cancertreatment2completed
NCT03447314
Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid Tumorstreatment1completed
NCT00088114
STA-4783 and Paclitaxel for Treatment of Solid Tumorstreatment1completed
NCT02082314
Prospective Study Determining the Pain Response, Functional Interference and Quality of Life in Patients Undergoing Radiofrequency Ablation Assisted Vertebroplasty/ CementoplastyNo drug interventionsNot AvailableNot Availablecompleted
NCT03942614
Nordic Pole Walking for Individuals With CancerNo drug interventionssupportive_careNot Availablecompleted
NCT00493155
A Multiple Ascending Dose Study of R1530 in Patients With Advanced Solid Tumors.No drug interventionstreatment1completed
NCT01030055
Bioavailability and Food Effect Study of TKI258 (CSF Capsules vs. FMI Capsules)in Adult Patients With Advanced Solid Tumorstreatment1completed
NCT01028755
To Determine Maximum Tolerated Dose of BAY79-4620 in Patients With Advanced Solid TumorsNo drug interventionstreatment1completed
NCT03299855
MoCA vs. MMS: Which Tool to Detect Cognitive Disorders in Oncogeriatric?No drug interventionsotherNot Availablecompleted
NCT02211755
Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumorstreatment1recruiting
NCT04595955
Effects of a Digital Patient Platform (CMyLife) for Patients With Chronic Myeloid Leukemia (CML) on Information Provision, Patient Empowerment, Medication Compliance, Guideline Adherence and Quality of LifeNo drug interventionshealth_services_researchNot Availablecompleted
NCT01337050
Asian Phase I Study Of PF-03446962basic_science1completed
NCT02828150
Integrative Parenteral Nutrition in Cancer PatientsNo drug interventionstreatmentNot Availablecompleted
NCT03359850
Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patientstreatment1completed
NCT02171650
BIBW 2992 in Patients With Advanced Solid Tumorstreatment1completed
NCT02612350
Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT00088023
Safety Study of PT-523 in Cancer Patients to Treat Solid Tumors Including a Preliminary Assessment of Effectivenesstreatment1terminated
NCT01514123
Study of VGX-100 Administered Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced Solid Tumorstreatment1completed
NCT00756223
Phase I Study of BI 831266 in Patients With Advanced Solid TumoursNo drug interventionstreatment1completed
NCT02875223
A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomastreatment1terminated
NCT00178308
Measuring Alterations of DNA in Human BloodNo drug interventionsNot AvailableNot Availablecompleted
NCT02760238
Myeloproliferative Neoplasms (MPNs) Patient RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT03168438
Letetresgene Autoleucel Engineered T Cells Alone and in Combination With Pembrolizumab in NY-ESO-1 Positive Multiple Myelomatreatment1terminated
NCT05838638
Serious Gaming for Chemotherapy-induced Nausea and VomitingNo drug interventionssupportive_careNot Availablerecruiting
NCT01938638
Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced CancerNo drug interventionstreatment1completed
NCT04080843
Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patientstreatment2completed
NCT03826043
THrombo-Embolic Event in Onco-hematologyNo drug interventionsscreeningNot Availablecompleted
NCT01343043
A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcomatreatment1completed
NCT02992743
Letetresgene Autoleucel Engineered T Cells in NY-ESO-1 Positive Participants With Advanced Myxoid/ Round Cell Liposarcomatreatment2completed
NCT04730843
A Study of ES102 (OX40 Agonist) in Patients With Advanced Solid TumorsNo drug interventionstreatment1completed
NCT00127543
Kid Cards: Teaching Kids About MedicinesNo drug interventionsotherNot Availablewithdrawn
NCT05441943
Lymphaticovenous Anastomosis as Treatment for LymphedemaNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT01358903
A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid TumorsNo drug interventionstreatment1completed
NCT05907603
Research Development(RD)13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7(CD7)+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML)No drug interventionstreatment0recruiting
NCT01646203
A Study of IMC-TR1 in Participants With Advanced Solid TumorsNo drug interventionstreatment1completed
NCT05573503
Effects of a Web Based Education Programme About Sexuality Aimed at Nurses That Care for Patients With CancerNo drug interventionshealth_services_researchNot Availableenrolling_by_invitation
NCT04787003
Oncolytic Virus (OVV-01) Injection in the Treatment of Patients With Advanced Solid TumorsNo drug interventionstreatment1recruiting
NCT00350090
A Study to Assess the Response Rate of PROCRIT (Epoetin Alfa) Given at a Dose of 40,000 Units Once a Week to Cancer Patients With Anemia Who Are Not Receiving Chemotherapy.treatment3terminated
NCT05943990
Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcomatreatment1terminated
NCT01404390
Japanese BAY80-6946 Monotherapy Phase I Studytreatment1completed
NCT00532090
A Multiple Ascending Dose Study of R4733 in Patients With Advanced Solid Tumors.treatment1completed
NCT01734564
Phase II Study With Hiltonol and Dendritic Cells in Solid Tumorstreatment2completed
NCT05729464
Risk Factors and Prediction Model of Cancer-associated Venous ThromboembolismNo drug interventionsNot AvailableNot Availablerecruiting
NCT00038064
Anemia in Patients With a Non-Myeloid Malignancytreatment3completed
NCT01739764
An Extension (Rollover) Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocoltreatment4completed
NCT02723864
Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumorstreatment1completed
NCT00730821
Phase I of BIBW 2992/BIBF 1120 Combination Therapy in Solid Tumorstreatment1completed
NCT02836821
Effect of Rifampicin on the Pharmacokinetics of Apatinibtreatment1completed
NCT00225121
Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF-00299804 In Patients With Advanced Solid Tumorstreatment1completed
NCT04607421
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancertreatment3active_not_recruiting
NCT01392521
Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor Copanlisib With MEK (Mitogen-activated Protein Kinase) Inhibitor Refametinib (BAY86-9766) in Patients With Advanced Cancertreatment1completed
NCT00450502
Safety of Batracylin in Patients With Solid Tumors and Lymphomastreatment1completed
NCT01567202
Study of DC Vaccination Against GlioblastomaNo drug interventionstreatment2unknown_status
NCT02366884
Clinical Evaluation of a New Form of Cancer Therapy (Atavistic Chemotherapy) Based on the Principles of Atavistic Metamorphosis (2011)treatment2unknown_status
NCT04181684
LITT Followed by Hypofractionated RT for Recurrent GliomasNo drug interventionstreatmentNot Availablerecruiting
NCT02715284
Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumorstreatment1recruiting
NCT00630084
Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinomatreatment4completed
NCT01999179
Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosishealth_services_researchNot Availablecompleted
NCT00417079
XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancertreatment3completed
NCT00001579
A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumorstreatment1completed
NCT02837679
Oncogeriatric Intervention and Follow-up at HomeNo drug interventionstreatmentNot Availableunknown_status
NCT01299987
Prospective Phase II Study of Intraoperative Radiotherapy (IORT) in Elderly Patients With Small Breast CancerNo drug interventionstreatmentNot Availablecompleted
NCT00210587
An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or Radiationtreatment3completed
NCT00399087
Phase I Trial of Docetaxel With Perifosinetreatment1completed
NCT00001387
Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory Malignancytreatment1completed
NCT00179387
Mind-Body Program for Cancer PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT01164033
A Study of RO5045337 in Patients With Solid Tumorstreatment1completed
NCT04482933
HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Gliomatreatment2not_yet_recruiting
NCT03303833
The GEOLynch Cohort StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02077933
Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumorstreatment1completed
NCT04388033
Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.treatment1 / 2unknown_status
NCT00264433
A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agenttreatment2completed
NCT01383733
A Study of RO5458640 in Patients With Advanced Solid TumorsNo drug interventionstreatment1completed
NCT00875433
Afatinib (BIBW 2992) QTcF Trial in Patients With Relapsed or Refractory Solid Tumourstreatment2completed
NCT00809133
Trial Exploring Afatinib (BIBW 2992) + Paclitaxel (Part A), Afatinib + Paclitaxel + Bevacizumab (Part B), Afatinib + Carboplatin (Part C) and Afatinib+ Paclitaxel +Carboplatin(Part D) in Patients With Advanced Solid Tumourstreatment1completed
NCT01304654
ALI/ARDS in Oncologic Pediatric PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT02280954
Indocyanine Green for Solid Tumorsdiagnostic1completed
NCT01828554
Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body Weightbasic_scienceNot Availablecompleted
NCT03553654
Low-dose CT-based Method for Detection of Subclinical Anthracycline-induced CardiotoxicityNo drug interventionsdiagnosticNot Availablecompleted
NCT00503451
A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumorstreatment1completed
NCT05442151
Evaluation Using FAPI-PET Targeting Cancer-associated FibroblastsNo drug interventionsdiagnosticNot Availablerecruiting
NCT02630251
Dose Escalation Study of GSK2820151 in Subjects With Advanced or Recurrent Solid TumorsNo drug interventionstreatment1terminated
NCT00386451
Comparing a Closing System Without a Needle With Positive Pressure to a Heparin Lock With Positive PressureNo drug interventionstreatmentNot Availablecompleted
NCT05907551
Study in Patients With Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic SolutionsNo drug interventionsNot AvailableNot Availablerecruiting
NCT02898051
Anti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous ThromboembolismNo drug interventionsNot AvailableNot Availableunknown_status
NCT01943851
A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD) and Clinical Activity of GSK525762 in Subjects With Relapsed, Refractory Hematologic Malignanciestreatment2completed
NCT04446351
Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid Tumorstreatment1recruiting
NCT04931251
Addressing Cancer-Related Financial Toxicity in Rural Oncology Care SettingsNo drug interventionshealth_services_researchNot Availablerecruiting
NCT01143753
A Study of RO5212054 (PLX3603) in Participants With BRAF V600-Mutated Advanced Solid TumorsNo drug interventionstreatment1completed
NCT00106353
Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumorstreatment1 / 2completed
NCT01524653
Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE)prevention2completed
NCT01251653
A Phase I Dose Escalation Trial of Afatinib Plus Gemcitabine or Plus DocetaxelNot AvailableNot Availablecompleted
NCT02203253
Efficacy of Thalidomide in Preventing Chemotherapy-induced Delayed Nausea and Vomitingprevention3completed
NCT02526953
Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patientstreatment3unknown_status
NCT00969553
Dose Finding Study of BI 6727 (Volasertib) in Patients With Various Solid Cancerstreatment1completed
NCT04772053
Molecular Disease Characterization Initiative (MDCI)No drug interventionsother2terminated
NCT02082977
A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma, Transformed Follicular Lymphoma, Other Non-Hodgkin's Lymphomas, Solid Tumors and Multiple MyelomaNo drug interventionstreatment1terminated
NCT02020577
Trial of Afatinib (BIBW 2992) + Cetuximab in Advanced Solid Tumourstreatment1completed
NCT04627077
Livestrong Cancer Institutes' Patient Reported Outcomes StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT01240577
An Early Phase I Study of IPdR Absorption, Metabolism, and Safety in Patients With Advanced Solid Tumors and Lymphomastreatment1completed
NCT03403777
Avelumab in Refractory Testicular Germ Cell Cancer.treatment2completed
NCT00321347
Intravenous (IV) Lidocaine for Opioid-refractory Paintreatment2withdrawn
NCT01348347
BI 6727 (Volasertib) Monotherapy Phase I Trial in Japanese Patients With Advanced Solid Tumourstreatment1completed
NCT04147247
A Trial to Find the Safe Dose for BI 905681 in Patients With Incurable Tumours or Tumours That Have SpreadNo drug interventionstreatment1completed
NCT04249947
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)treatment1active_not_recruiting
NCT00040547
Farnesyl Protein Transferase Inhibitor (FPTI) in Combination With Docetaxel in Advanced Solid Tumors (Study P01964)(COMPLETED)No drug interventionstreatment1completed
NCT00291447
111In-ch806 in Patients With Advanced Tumours Expressing the 806 AntigenNo drug interventionstreatment1completed
NCT00071045
Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family MembersNo drug interventionsNot AvailableNot Availablerecruiting
NCT01702545
Determination of Drugs and Their Metabolites in Hospitalized PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT02543645
A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancertreatment1terminated
NCT02944045
Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised Patientstreatment3unknown_status
NCT02106845
Effect of Regorafenib on Digoxin and Rosuvastatin in Patients With Advanced Solid Malignant Tumors.treatment1completed
NCT01966445
Dose Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2849330 in Subjects With Advanced Her3-Positive Solid TumorsNo drug interventionstreatment1completed
NCT00516945
A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B CarrierstreatmentNot Availablecompleted
NCT01445145
An Exploratory Study of the Use of Five Wishes as a Tool for Advanced Care Planning in Young Adults With Metastatic, Recurrent, or Progressive Cancer or HIV InfectionNo drug interventionsNot AvailableNot Availablecompleted
NCT01534598
FdCyd and THU for Advanced Solid Tumorstreatment1completed
NCT00940498
Study of PF-05212384 (Also Known as PKI-587)Administered Intravenously To Subjects With Solid Tumorstreatment1completed
NCT00900198
Collection of Tissue Samples for Cancer ResearchNo drug interventionsNot AvailableNot Availablerecruiting
NCT01287598
BAY73-4506 Probe Substrate Studytreatment1completed
NCT00906698
Afatinib and Vinorelbine in Tumours Known to Overexpress EGFR and/or HER2treatment1completed
NCT02647398
Study Comparing Two Strategies of Exercise in Breast and Colon Cancer Survivors and Their Impact on FatigueNo drug interventionssupportive_careNot Availablecompleted
NCT01123005
Imaging and Biomarkers of Hypoxia in Solid Tumorsdiagnostic1terminated
NCT03569605
Promoting Physical Activity in Young Adult Cancer Survivors Using mHealth and Adaptive Tailored Feedback StrategiesNo drug interventionssupportive_careNot Availablecompleted
NCT04991805
Descriptive Study of the Incidence of Malignancy in Severe Asthma Patients Receiving Benralizumab and Other Biologic Therapy, a Post Authorization Safety StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT02689505
Weekly BI 836880 in Patients With Advanced Solid Tumorstreatment1completed
NCT00557505
A Study Of PF-03732010 In Patients With Advanced Solid TumorsNo drug interventionstreatment1completed
NCT00120705
Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapytreatment2completed
NCT06048705
Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung Cancertreatment1terminated
NCT04075305
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05675605
A Study of TY-1091 in Patients With Advanced Solid TumorsNo drug interventionstreatment1 / 2recruiting
NCT01695005
A Study of LY3039478 in Participants With Advanced Cancertreatment1completed
NCT06285097
A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumorstreatment1recruiting
NCT00141297
A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancertreatment1completed
NCT00269997
A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia as a Result of Cancer Treatment With Cisplatin, a Platinum-containing Chemotherapy Drugtreatment2completed
NCT00398697
Phase I Perifosine and Gemcitabine Studytreatment1completed
NCT04008797
A Study of E7386 in Combination With Other Anticancer Drug in Participants With Solid Tumortreatment1recruiting
NCT02663297
Administration of T Lymphocytes for Prevention of Relapse of LymphomasNo drug interventionstreatment1active_not_recruiting
NCT05298683
A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitortreatment2not_yet_recruiting
NCT02507583
Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant GliomaNo drug interventionstreatment1completed
NCT04267861
M7824 Related Adverse Effects in Adults With CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04154761
Resection of the Inferior Vena Cava Due to Tumor InvolvementNo drug interventionsNot AvailableNot Availablecompleted
NCT02752061
Potlako: A Programmatic Intervention to Improve Access to Timely Oncology CareNo drug interventionshealth_services_researchNot Availablecompleted
NCT04300361
Identifying Novel Variants in the DPYD Gene in Patients of Non-Western DescentNo drug interventionsNot AvailableNot Availableunknown_status
NCT00024661
Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumorstreatment1completed
NCT02202928
Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal CancerNo drug interventionstreatment2unknown_status
NCT06270628
Personalized Live-remote Exercise Training for Cancer SurvivorsNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT01222728
Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT02690428
Immunostimulating Interstitial Laser Thermotherapy in Solid CancersNo drug interventionstreatmentNot Availableterminated
NCT00145028
Determination of Carboplatin's Optimal Plasmatic ExposureNot AvailableNot Availablecompleted
NCT00496028
Phase I Study in Patients With Solid Tumourstreatment1completed
NCT00783328
A Study Of PF-00299804 In Patients In Japan With Advanced Malignant Solid Tumorstreatment1completed
NCT02386111
A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinomatreatment1terminated
NCT00481611
Cancer Markers Associated With Occupational Exposure to TrichloroethyleneNo drug interventionsNot AvailableNot Availablecompleted
NCT02660411
Impact of Anesthesia Maintenance Methods on Long-term SurvivalpreventionNot Availablecompleted
NCT01905111
A Study of BI 853520 in Japanese and Taiwanese Patients With Various Types of Advanced or Metastatic Cancertreatment1completed
NCT06018311
Exercising Together for Hispanic Prostate Cancer Survivor-Caregiver DyadsNo drug interventionspreventionNot Availablerecruiting
NCT00962611
BAY80-6946 Open Label, Phase I Study in Patients With Advanced Cancertreatment1completed
NCT00811993
A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumorstreatment1terminated
NCT03194893
A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancertreatment3recruiting
NCT01009593
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)treatment3terminated
NCT03504293
The Diagnostic Value of Combinatory EUS and ERCP in Unclear LesionsNo drug interventionsNot AvailableNot Availablecompleted
NCT01004393
Methylnaltrexone for Opioid-induced Constipation in Cancer Patientssupportive_care2completed
NCT03096093
Investigation of a Therapeutic Vaccine (ACIT-1) in CancerNo drug interventionstreatment1 / 2active_not_recruiting
NCT03967093
A Study of BXQ-350 in Children and Young Adults With Relapsed Solid Tumorstreatment1terminated
NCT05077371
Peer Support Program in Cancer Patients Elkar LaguntzaNo drug interventionssupportive_careNot Availablerecruiting
NCT00327171
Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancertreatment2completed
NCT02836171
Effect of Itraconazole on the Pharmacokinetics of Apatinibtreatment1completed
NCT04342871
An Evaluation of the Families Addressing Cancer Together (FACT) InterventionNo drug interventionssupportive_careNot Availablecompleted
NCT01146171
Japanese Phase 1 Study of BMS-844203 (CT322)treatment1withdrawn
NCT02889978
The Circulating Cell-free Genome Atlas StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02944578
Topical Curcumin for Precancer Cervical Lesionstreatment2suspended
NCT02629978
Radiofrequency Ablation of Malignant Pulmonary NodulesNo drug interventionstreatmentNot Availableunknown_status
NCT03269578
Sample Collection and Tracking for the Developmental Therapeutics ClinicNo drug interventionsNot AvailableNot Availablerecruiting
NCT02897778
Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumorstreatment1completed
NCT02555878
A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participantsprevention3completed
NCT00033878
Study of Noni in Cancer PatientsNo drug interventionstreatment1completed
NCT03918278
A Study of MK-0482 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-0482-001)treatment1active_not_recruiting
NCT04568278
Mobile Application Using the PRO-CTCAE to Improve Patients' Participation in Symptom Management During Treatment.No drug interventionssupportive_careNot Availableunknown_status
NCT03666988
First Time in Humans (FTIH) Study of GSK3368715 in Participants With Solid Tumors and Diffuse Large B-cell Lymphoma (DLBCL)No drug interventionstreatment1terminated
NCT05256888
Time-Restricted Eating to Address Persistent Cancer-Related FatigueNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT00670488
Dose Escalation Study With MK-2206 in Patients With Locally Advanced or Metastatic Solid Tumors (MK-2206-002)treatment1completed
NCT00606788
Therapy Study of Automated Protocolized vs. Physician-Directed Non-Protocolized WeaningNo drug interventionstreatmentNot Availablesuspended
NCT04067388
iKnife REIMS ProjectNo drug interventionsNot AvailableNot Availablerecruiting
NCT05593107
68Ga-N188 PET/CT Imaging in MalignancyNo drug interventionsdiagnosticNot Availablerecruiting
NCT06464107
Endometrial Cell Collection With the PadKitNo drug interventionsscreeningNot Availablerecruiting
NCT02964507
Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancertreatment1terminated
NCT00074607
Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabinetreatment1terminated
NCT00822809
CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancerstreatment3completed
NCT04461509
High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomyother2active_not_recruiting
NCT04152109
Integrative and Complementary Health Practices (PICS)No drug interventionstreatmentNot Availablerecruiting
NCT00046709
Marijuana for Cancer Paintreatment1 / 2terminated
NCT05653609
Sensitivity and Specificity of the Clinical Classifications Generated by the Cureety Digital Telemonitoring ToolNo drug interventionsNot AvailableNot Availablecompleted
NCT01335256
Clinical Study to Evaluate Safety and Maximum Tolerated Dose of BAY1000394 Given in a 4 Week on / 2 Week Off Schedule in Subjects With Advanced Malignanciestreatment1completed
NCT05733156
Abscopal Effect From the Low-dose Radiotherapy in Polymetastatic Cancer Patients Receiving Stereotactic RadiotherapyNo drug interventionstreatmentNot Availablerecruiting
NCT04721756
Early Clinical Evaluation of 18F-LY3546117 in Tumor ImagingNo drug interventionsdiagnostic0unknown_status
NCT03269656
Age Gene/Environment Susceptibility Reykjavik StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00475956
Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumourstreatment1completed
NCT01471756
Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal NeoplasiaNo drug interventionstreatment4completed
NCT02293785
GREAT - Good Response With Appropriate TreatmentNot AvailableNot Availablecompleted
NCT01145885
BI 6727 (Volasertib) Human ADME Trial in Various Solid Tumourstreatment1completed
NCT00302185
Acupuncture in Palliative Cancer CareNo drug interventionstreatment3completed
NCT01338285
Association of Formaldehyde Exposure to Myeloid Leukemia in Workers in Guangdong, ChinaNo drug interventionsNot AvailableNot Availablecompleted
NCT02861885
Detection and Characterization of Sessile Serrated Lesions (SSL) of the Right ColonNo drug interventionsNot AvailableNot Availableunknown_status
NCT03037385
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumorstreatment1 / 2completed
NCT05155215
Study to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Mantle Cell Lymphomatreatment1 / 2unknown_status
NCT00293215
Biodistribution Study of CMD-193 in Patients With Advanced Tumours Expressing the Lewis-Y Antigentreatment1terminated
NCT06482515
Take the Reins: The Effects of Nutrient Timing on Cancer-related FatigueNo drug interventionssupportive_care2not_yet_recruiting
NCT00043615
Collection of Blood, Bone Marrow, Tumor or Tissue SamplesNo drug interventionsNot AvailableNot Availablecompleted
NCT04644315
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumorstreatment2terminated
NCT03694015
SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone MetastasesNo drug interventionstreatmentNot Availablerecruiting
NCT01684215
A Study Of Oral Palbociclib (PD-0332991), A CDK4/6 Inhibitor, As Single Agent In Japanese Patients With Advanced Solid Tumors Or In Combination With Letrozole For The First-Line Treatment Of Postmenopausal Japanese Patients With ER (+) HER2 (-) Advanced Breast Cancertreatment2completed
NCT04312737
Evaluation of in Vitro Devices on Self-collected Vaginal Swab and Urine Sample for Testing of Human Papilloma VirusNo drug interventionsNot AvailableNot Availablecompleted
NCT02215837
Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric CancerNo drug interventionstreatment2unknown_status
NCT03521037
Rucaparib Hepatic Impairment Study in Patients With a Solid Tumorother1completed
NCT05944237
HTL0039732 in Participants With Advanced Solid Tumourstreatment1 / 2recruiting
NCT03566732
ERANet-LAC CODE: International Care Of the Dying EvaluationNo drug interventionsNot AvailableNot Availablecompleted
NCT03699332
Multi-modality Imaging in Peritoneal Carcinomatosis of Colorectal Origindiagnostic1 / 2unknown_status
NCT01962532
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Patients With Advanced or Refractory Solid Tumors or Lymphomatreatment1completed
NCT00678132
AZD2281 and Cisplatin Plus Gemcitabine to Treat Solid Tumor Cancerstreatment1completed
NCT02078752
A Study Of PF-06647263 In Patients With Advanced Solid TumorsNo drug interventionstreatment1terminated
NCT04566952
Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancertreatment2unknown_status
NCT00386152
A Study Comparing Two Different PROCRIT Doses to a Dose of ARANESP in Anemic Cancer Patients Receiving Chemotherapytreatment2terminated
NCT03760952
Human Leukocyte Antigen Typing and Tumor Antigen Expression ProfilingNo drug interventionsNot AvailableNot Availablecompleted
NCT02909452
Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumorstreatment1completed
NCT06271252
A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Studytreatment1recruiting
NCT01168752
Study of Debio 0932 in Patients With Advanced Solid Tumours or LymphomaNo drug interventionstreatment1completed
NCT00102752
Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancertreatment1 / 2completed
NCT02324452
Safety, Feasibility and Cost-effectiveness of Genotype-directed Individualized Dosing of FluoropyrimidinestreatmentNot Availablecompleted
NCT02646852
A Phase I Study of PLX038 in Patients With Advanced Solid TumorsNo drug interventionstreatment1completed
NCT03221400
PEN-866 in Patients With Advanced Solid Malignanciestreatment1 / 2unknown_status
NCT01427400
The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstructiontreatment4unknown_status
NCT02783300
An Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphomatreatment1completed
NCT06354959
Prehab for Lung and Esophageal CancerNo drug interventionssupportive_careNot Availablerecruiting
NCT03561259
A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjectstreatment2recruiting
NCT00094159
Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumorstreatment1completed
NCT05940259
68Ga-P3 PET/CT Imaging in ProstateNo drug interventionsdiagnosticNot Availablerecruiting
NCT06005259
Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX)prevention4not_yet_recruiting
NCT01462175
A First-In-Human Study of RO5503781 in Participants With Advanced Malignancies Except Leukemiatreatment1completed
NCT00428675
A New Tool for Assessing Fatigue in Individuals With Advanced CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05280275
A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligibletreatment1 / 2recruiting
NCT04964375
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK043 in Patients With Advanced Solid TumorNo drug interventionstreatment1unknown_status
NCT04679675
Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer TrialNo drug interventionshealth_services_researchNot Availablecompleted
NCT01562275
A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0973 in Combination With GDC-0068 When Administered in Participants With Locally Advanced or Metastatic Solid Tumorstreatment1completed
NCT06362070
Comparison of Outcomes of Multiple Platforms for Assisted Robotic - GastrectomyNo drug interventionstreatmentNot Availablerecruiting
NCT00838370
Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidinesprevention1completed
NCT04144842
Phase 1 Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of ATOR-1017No drug interventionstreatment1completed
NCT01555242
A Study of Aneustat (OMN54) in Patients With Advanced Cancer and LymphomasNo drug interventionstreatment1completed
NCT00161642
Study Evaluating CMD-193 in Advanced Malignant Solid TumorsNo drug interventionstreatment1completed
NCT01885299
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRTNo drug interventionsNot AvailableNot Availablerecruiting
NCT02666599
Per-operating Use of a Probe for Detection of β+No drug interventionsdiagnosticNot Availableterminated
NCT04930406
Impact of Physical Therapy Intervention on Foot and Ankle FunctionNo drug interventionsNot AvailableNot Availablerecruiting
NCT02908906
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancerstreatment1 / 2active_not_recruiting
NCT00034606
Comparing 3 Schedules of Alimta Plus Gemzartreatment2completed
NCT01538706
Hospital-based Home Care for Children With CancerNo drug interventionssupportive_careNot Availablecompleted
NCT01270906
Safety of CHIR-258 (TKI258) in Advanced Solid Tumorstreatment1terminated
NCT00557206
Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancertreatment2terminated
NCT02004106
A Study to Evaluate Safety, Pharmacokinetics, and Efficacy of RO6895882 in Participants With Advanced and/or Metastatic Solid Tumorstreatment1completed
NCT04991506
A Study of ES102 (OX40 Agonist) in Combination With JS001 in Patients With Advanced Solid Tumorstreatment1recruiting
NCT00270049
Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemiatreatment2completed
NCT00454649
Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumortreatment1completed
NCT05377749
The Families Addressing Cancer Together Intervention for Parents With CancerNo drug interventionssupportive_careNot Availablecompleted
NCT06105749
Biennial CEM in Women With a Personal History of Breast CancerNo drug interventionsscreeningNot Availablerecruiting
NCT01037049
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 WeeksNo drug interventionsother2unknown_status
NCT02854449
Tumor Response in Hypofractionated RadiotherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT02420249
Qigong for Breast Cancer SurvivorsNo drug interventionstreatmentNot Availableunknown_status
NCT00001449
A Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer Patientstreatment1completed
NCT02454036
Biobehavioral Intervention in Gynecologic Oncology PatientsNo drug interventionssupportive_care2completed
NCT00877136
A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®No drug interventionsNot AvailableNot Availablecompleted
NCT03387436
The "Hand-in-Hand Study": Improvement of Quality of Life in Palliative Cancer Patients Through Collaborative Advance Care PlanningNo drug interventionssupportive_careNot Availableunknown_status
NCT05918536
Orthopedic Oncology Surgery: Navigation, Intraoperative Imaging and Virtual RealityNo drug interventionsNot AvailableNot Availablerecruiting
NCT00388336
PROCRIT (Epoetin Alfa) 60,000 Units Administered Once Every Two Weeks in Anemic Cancer Patients Who Are Not Receiving Chemotherapy or Radiation Therapytreatment2completed
NCT01317836
PET-CT in Diagnosis of Pancreatic Cystic NeoplasmsNo drug interventionsNot AvailableNot Availablecompleted
NCT05150236
EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPCtreatment2active_not_recruiting
NCT00277836
Study Evaluating MST-997 in Advanced Malignant Solid Tumorstreatment1terminated
NCT00569036
Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumorstreatment1completed
NCT05716113
CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBLNo drug interventionstreatment0recruiting
NCT00980213
Evaluation of the Cost and Effectiveness Sunitinib Compared to Interferon-Alfa in FinlandNot AvailableNot Availablecompleted
NCT02606513
MR Urography vs CT UrographyNo drug interventionsdiagnosticNot Availablecompleted
NCT01233713
Hartmann's Versus Primary Anastomosis in Left-sided Colon PerforationNo drug interventionstreatment2 / 3completed
NCT04288518
Molecular Imaging of Brain Tumors Using Labeled Technetium-99m 1-Thio-D-Glucose.No drug interventionsdiagnostic1 / 2completed
NCT01259518
Dose Escalation Study of TriN2755 in Advanced Solid Tumors and SarcomasNo drug interventionstreatment1unknown_status
NCT02810418
Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumorstreatment1 / 2completed
NCT00817518
A Dose-Escalating Study of RO4987655 in Patients With Advanced Solid Tumorstreatment1completed
NCT02116218
Assessment of Cancer Pain in Emergency Department in Traditional Chinese MedicineNo drug interventionstreatmentNot Availablewithdrawn
NCT00859118
Pharmacodynamic Study of Axitinib in Patients With Advanced Solid Malignanciestreatment1completed
NCT02807519
Salivary Cytokines as Biomarker for Oral HealthNo drug interventionsNot AvailableNot Availablecompleted
NCT03373019
Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)treatment2unknown_status
NCT00979641
Biweekly Avastin and Docetaxel as the First Line Treatment for Patients With Metastatic Breast Cancertreatment2terminated
NCT02292641
Beyond TME OriginsNo drug interventionstreatmentNot Availablerecruiting
NCT02379741
ADC-1013 First-in-Human Studytreatment1completed
NCT02145741
Weekly Intravenous Administrations of BI 836845 in Japanese Patients With Advanced Solid Tumourstreatment1completed
NCT02721641
A Continuation Study of Herceptin (Trastuzumab) in Participants With Metastatic or Locally Advanced Cancertreatment3completed
NCT01976741
Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)treatment1completed
NCT06346041
Safety and Efficacy of Intravenous IDOV-SAFETM in Patients With Advanced Solid TumorsNo drug interventionstreatment0recruiting
NCT00273741
Ritalin: Antiasthenic Effect of Methylphenidate (Ritalin) in Palliative Care in Cancer Patientstreatment3terminated
NCT06494241
Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) StudyNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00216541
A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapytreatment4completed
NCT01519817
Cancer Vaccine Targeting Brachyury Protein in Tumorstreatment1completed
NCT01881217
First-in-man Dose Escalation Study of BAY1179470 in Patients With Advanced, Refractory Solid TumorsNo drug interventionstreatment1completed
NCT06289517
PET Imaging of 68Ga-Her2-affibody in Tumors With High Her2 ExpressionNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT04157517
A Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumorsother1 / 2completed
NCT02155634
Continuous Lenalidomide Therapy Versus Observation Following Induction Without Lenalidomide, Pomalidomide or Thalidomide in Myelomatreatment3withdrawn
NCT01313234
Educational Intervention Targeting Nurses Attitudes and Knowledge About Cancer-related Pain ManagementNo drug interventionshealth_services_researchNot Availablecompleted
NCT03945734
Expressive Helping for Chinese-Speaking Cancer Patients and SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT03092934
A Study of AK-01 (LY3295668) in Solid Tumorstreatment1 / 2completed
NCT00048334
Depsipeptide to Treat Thyroid and Other Advanced Cancerstreatment1completed
NCT05839834
Blood Cell RNA-Based Cancer DetectionNo drug interventionsNot AvailableNot Availablerecruiting
NCT00599924
Study Of Sunitinib Plus FOLFOX In Patients With Solid Tumorstreatment1completed
NCT03792724
Phase I-II Study of Intratumoral Urelumab Combined With Nivolumab in Patients With Solid Tumorstreatment1 / 2unknown_status
NCT00113724
Study of TPI 287 in Patients With Advanced Malignanciestreatment1completed
NCT02111824
A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and Therapydiagnostic1terminated
NCT00719524
AVE8062 in Combination With Platinum-taxane Doublet in Advanced Solid Tumortreatment1completed
NCT03515824
Study of MK-1697 in Participants With Advanced Solid Tumors (MK-1697-001)No drug interventionstreatment1terminated
NCT05490524
Smart Living Homes: GATEKEEPER System With Patients With Cancer and Dementia in CyprusNo drug interventionssupportive_careNot Availableunknown_status
NCT00618124
A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Togethertreatment1completed
NCT05980416
Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2treatment1recruiting
NCT01605916
Investigate the Safety and Tolerability of AZD6244 Monotherapy or + Docetaxel in Japanese Patients With Advanced Solid Malignancies or Non-Small Cell Lung Cancertreatment1completed
NCT01206816
An Open Label Phase I Dose Escalation Trial of Intravenous BI 6727 (Volasertib)in Combination With Oral BIBW 2992 (Afatinib) in Patients With Advanced Solid Tumourstreatment1completed
NCT02014116
A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their BodyNo drug interventionstreatment1terminated
NCT05100316
Screening Protocol for Preliminary Eligibility Determination for Adoptive Cell Therapy TrialsNo drug interventionsother2terminated
NCT01802996
Evaluate the Efficacy of Magnesium Isoglycyrrhizinate in the Prevention of Chemotherapy Related Acute Liver InjuryNo drug interventionsprevention4unknown_status
NCT03435796
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T CellsNo drug interventionsother2 / 3recruiting
NCT05949996
Evaluation of a Program for Routine Implementation of Symptom Distress Screening and Referral in Cancer CareNo drug interventionshealth_services_researchNot Availablerecruiting
NCT05636696
COMPANION: A Couple Intervention Targeting Cancer-related FatigueNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT03981796
A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancertreatment3active_not_recruiting
NCT02215096
Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancertreatment1completed
NCT03626896
Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) PatientsNo drug interventionsdevice_feasibilityNot Availablecompleted
NCT04371796
Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLCtreatment2unknown_status
NCT00761696
A Phase 1 Study of IPI-926 in Patients With Advanced and/or Metastatic Solid Tumor Malignanciestreatment1completed
NCT00046696
A Study of NM-3 Administered Orally in Patients With Advanced Solid Tumors.No drug interventionstreatment1completed
NCT00400296
A Study of R547 in Patients With Advanced Solid Tumors.treatment1completed
NCT00106158
Safety Study of NY-ESO-1 Protein Vaccine to Treat Cancer Expressing NY-ESO-1No drug interventionstreatment1completed
NCT00001158
Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune SystemNo drug interventionsNot AvailableNot Availablecompleted
NCT02158858
A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosistreatment1 / 2active_not_recruiting
NCT02659358
Evaluating the Use of Wearable Biosensors and PROs to Assess Performance Status in Patients With CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05103358
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)treatment2active_not_recruiting
NCT06003335
Increasing Physical Activity Through Personalised Motivational Messaging to Improve Cognitive Function in Lung Cancer SurvivorsNo drug interventionshealth_services_researchNot Availablenot_yet_recruiting
NCT00050635
STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrheaprevention4completed
NCT00046735
Phase 1 Study OF CDC-501 in Patients With Solid Tumorstreatment1completed
NCT01051635
A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and LymphomasNo drug interventionstreatment1completed
NCT02706535
A Cross-over Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics (PK) of GSK525762 in Healthy Female Subjects of Non Child Bearing Potentialtreatment1completed
NCT04659135
ASCO Survey on COVID-19 in Oncology (ASCO) RegistryNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01156935
Effects of Laugh-yoga Intervention on Mood and Quality of Life Among Oncologic Patients in a Oncologic Clinic Setting.No drug interventionssupportive_careNot Availableunknown_status
NCT01409135
A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4treatment1completed
NCT02171663
Dose Escalation Study of BIBW 2992 in Patients With Advanced Solid Tumorstreatment1completed
NCT02984163
Alberta Cancer Exercise Hybrid Effectiveness-Implementation StudyNo drug interventionssupportive_careNot Availablerecruiting
NCT02442063
Phase Ib Study of Radium Ra 223 Dichloride in Combination With Paclitaxel in Cancer Subjects With Bone LesionsNot Available1completed
NCT04932863
BNT162b2 Messenger Ribonucleic Acid (mRNA) Covid-19 Vaccine in Cancer Patients on Active TreatmentNot AvailableNot Availableunknown_status
NCT04200963
A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinomatreatment1completed
NCT03948763
A Study of mRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001)treatment1completed
NCT05534386
A Self-management Based Survivorship Intervention for Chinese Cancer SurvivorsNo drug interventionstreatmentNot Availablerecruiting
NCT05322486
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable MetastasesNo drug interventionsNot AvailableNot Availableunknown_status
NCT00104286
Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Solid Tumorstreatment1 / 2terminated
NCT00487786
Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder Cancertreatment1completed
NCT00213239
A Dose Finding Study of Remifentanil and Propofol for Lumbar Punctures in Childrentreatment1 / 2completed
NCT02360839
The Use of FNA and FNB in the Optimization of EUS-assisted Tissue SamplingNo drug interventionsdiagnosticNot Availablecompleted
NCT00838539
Study Evaluating Neratinib In Combination With Temsirolimus In Subjects With Solid Tumorstreatment1completed
NCT05431439
Omics of Cancer: OncoGenomicsNo drug interventionsNot AvailableNot Availablewithdrawn
NCT04833439
The Effect of a Fasting MimickINg Diet on the Immune SystemNo drug interventionsbasic_scienceNot Availablecompleted
NCT01445522
ABT-888 Plus Metronomic Cyclophosphamide to Treat Cancertreatment1completed
NCT05980325
Exercise For Fighting Oncology Repercussions After TreatmentNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT02747225
Measuring the Electrical Properties of Malignant Tissues In VivoNo drug interventionsNot AvailableNot Availableunknown_status
NCT02168725
Dose-escalation, Safety and Pharmacokinetic Study of Briciclib in Advanced Solid Tumorstreatment1terminated
NCT00195325
Study Evaluating TTI-237 in Advanced Malignant Solid Tumors.educational_counseling_training1terminated
NCT00606125
Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid Tumorstreatment1completed
NCT01324830
Monotherapy Dose Finding With BI 847325 in Solid TumoursNo drug interventionstreatment1completed
NCT05860530
Bioequivalence Study of Two Olaparib Tablets in Patients With CancerstreatmentNot Availablecompleted
NCT03360630
Anti-PD-1 Alone or Combined With Autologous Cell Therapy in Advanced NSCLCNo drug interventionstreatment1 / 2completed
NCT06094530
18F-FAPI-RGD PET/CT in Various Tumor TypesNo drug interventionsNot AvailableNot Availablerecruiting
NCT01297530
Clinical Study to Evaluate the Maximum Tolerated Dose of BAY87-2243 in Patients With Advanced MalignanciesNo drug interventionstreatment1terminated
NCT03330730
Evaluation of the Efficiency of the IsereADOM Home-care Service Package in the Prevention of Unplanned Hospitalizations of Patients With CancerNo drug interventionspreventionNot Availablecompleted
NCT01964430
Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)treatment3completed
NCT04495530
Information Needs Around Parenteral nUTrition in CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05874648
PRediction Of Five Usual Tumors Using Blood Test for Risk Assessment and Early DetectionNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01419548
ABT-888, Carboplatin, and Paclitaxel for Cancer With Liver or Kidney Problemstreatment1withdrawn
NCT00343148
Pharmacokinetic Study of a Single Dose of AVI-4126 (RESTEN-NG®) in Cerebral Spinal FluidNo drug interventionstreatment1completed
NCT02900248
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician ChoiceNo drug interventionsNot AvailableNot Availableterminated
NCT01255748
Registry Study for Radiation Therapy OutcomesNo drug interventionsNot AvailableNot Availablerecruiting
NCT05935748
Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)treatment2recruiting
NCT02862457
Study of Epacadostat (INCB024360) Alone and In Combination With Pembrolizumab (MK-3475) With Chemotherapy and Pembrolizumab Without Chemotherapy in Participants With Advanced Solid Tumors (MK-3475-434)treatment1completed
NCT03602157
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCLtreatment1recruiting
NCT03065257
Endoscopic Resection Multicenter RegistryNo drug interventionsNot AvailableNot Availableunknown_status
NCT06150157
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative NeoplasmsNo drug interventionstreatment1recruiting
NCT06505057
Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female Cancer Patients (HKCH)No drug interventionsotherNot Availablerecruiting
NCT02528357
GSK3174998 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (ENGAGE-1)treatment1completed
NCT00265057
Study of ADH-1 Given Intravenously to Patients With Solid Tumorstreatment1 / 2completed
NCT02423057
Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid TumorsNo drug interventionstreatment1suspended
NCT03470857
Oxidoreductive Balance and Lysosomal Activity in Cancer Patients.No drug interventionsNot AvailableNot Availablecompleted
NCT05834426
Omic Technologies Applied to the Study of B-cell Lymphoma for the Discovery of Diagnostic and Prognosis BiomarkersNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01562626
Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumorstreatment1 / 2suspended
NCT01251926
EZN-2208 (Pegylated SN-38) in Combination With Bevacizumab in Refractory Solid Tumorstreatment1completed
NCT02194426
First-in-human Study to Investigate the Safety, Tolerability and Blood Levels of the Test Drug MP0250 in Cancer Patientstreatment1 / 2completed
NCT03889626
The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancertreatment3unknown_status
NCT03084926
First-in-human Study to Investigate Safety, Blood Levels and Activity of MP0274 in Cancer Patients With HER2-positive Solid TumorsNo drug interventionstreatment1completed
NCT03468426
A Study to Test Different Doses of BI 836880 Combined With Ezabenlimab in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumourstreatment1active_not_recruiting
NCT02330926
Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapyprevention3completed
NCT02636426
Sorafenib Administered Using a High-dose, Pulsatile Regimen: a Phase I Exposure Escalation Studytreatment1completed
NCT06581666
Current Awareness, Perspective and Knowledge on Social Egg FreezingNo drug interventionsNot AvailableNot Availablerecruiting
NCT01986166
A Study of MEHD7945A and Cobimetinib in Patients With Locally Advanced or Metastatic Cancers With Mutant KRAStreatment1completed
NCT05667766
Minimising Adverse Drug Reactions and Verifying Economic Legitimacy in Children (MARVEL-PIC)No drug interventionssupportive_careNot Availablerecruiting
NCT02405065
Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetics and Anti-tumor Activity of HM95573No drug interventionstreatment1completed
NCT02005965
Low Rectal Cancer Study (MERCURY II)No drug interventionsNot AvailableNot Availableunknown_status
NCT05176665
EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancerstreatment1 / 2recruiting
NCT00651365
A Safety and Dose-finding Study of JNJ-38877605 in Patients With Advanced or Refractory Solid Tumors.treatment1terminated
NCT00923065
Data Collection, Clinical Care and Interventions in CCR, NCINo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT05272865
Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THCother1 / 2not_yet_recruiting
NCT06247865
BIO-CHECKPOINT 0 Biomarkers to Identify Oncology Patients on ICPI at Greater Risk of irAENo drug interventionsNot AvailableNot Availablerecruiting
NCT05112965
An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C)treatment3recruiting
NCT03422874
Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphomatreatment1withdrawn
NCT02345174
Immuno Positron Emission Tomography Study of GSK2849330 in Subjects With Human Epidermal Growth Factor Receptor 3-Positive Solid TumorsNo drug interventionsother1completed
NCT01008774
START: Swiss Taxotere Alopecia Prevention TrialNo drug interventionspreventionNot Availablecompleted
NCT05578274
Abscopal Effect From Low-dose Radiotherapy in Metastatic Cancer Combined With Stereotactic Body RadiotherapyNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT01362374
Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid Tumorstreatment1completed
NCT01992874
Relative Bioavailability of Pimasertib in Cancer Patientstreatment1completed
NCT03102320
Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumorstreatment1completed
NCT01778920
Pilot and Feasibility Study of the Imaging Potential of EC17: Intraoperative Folate-fluorescein Conjugate (EC17) Lung Cancer (CA)No drug interventionsdiagnostic1completed
NCT04949282
Spanish Series of Patients Treated With the Radionuclide Lutetium177Not AvailableNot Availablerecruiting
NCT01481831
Efficacy and Safety of Palonosetron Hydrochloride in the Prevention of Nausea and Vomitingtreatment4completed
NCT04635631
STUDY OF TALAZOPARIB MONOTHERAPY IN CHINESE PARTICIPANTS WITH ADVANCED SOLID TUMORStreatment1completed
NCT00031031
Kanglaite Injection Phase I StudyNo drug interventionstreatment1completed
NCT02031731
The Pharmacokinetics and Safety of Onartuzumab (MetMAb) in Chinese Patients With Locally Advanced or Metastatic Solid Tumorstreatment1completed
NCT03549273
Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial LesionsNo drug interventionstreatment2recruiting
NCT00057473
A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid Tumorstreatment2completed
NCT02754973
Integrated Experiential Training Program With Coaching by Nursing Students in Childhood Cancer PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT01682473
A Study of ZSTK474 in Japanese Patients With Advanced Solid MalignanciesNo drug interventionstreatment1completed
NCT01655927
Efficacy of Tranexamic Acid in Brain Tumor Resectionstreatment3unknown_status
NCT00167427
Genotoxicity Assessment for Patients Undergoing Radiation TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT02620527
Concordance Between ctDNA Assay and FoundationOneNo drug interventionsNot AvailableNot Availablecompleted
NCT02732327
Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancertreatment2terminated
NCT00027027
Safety Study of rhuMAb 2C4 to Treat Advanced Solid TumorsNo drug interventionstreatment1completed
NCT03535727
A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancertreatment1 / 2completed
NCT03210727
CAREgiver Study for Patients Undergoing HSCTNo drug interventionssupportive_careNot Availablecompleted
NCT00479076
A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patientstreatment1completed
NCT04706676
Integrative Neuromuscular Training in Adolescents and Children Treated for CancerNo drug interventionspreventionNot Availablerecruiting
NCT02171676
BIBW 2992 After Administration of Docetaxel in Patients With Advanced Solid Tumorstreatment1completed
NCT00095160
Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ TumorsNo drug interventionstreatment1completed
NCT02895360
Phase 1/2a Study of BAL101553 as 48-hour Infusions in Patients With Advanced Solid Tumors or Recurrent Glioblastomatreatment1 / 2completed
NCT02017860
Study to Collect and Assess Long-term Safety of Everolimus in Patients Who Are on Everolimus Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator.treatment2completed
NCT02891460
Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC PatientsNo drug interventionstreatmentNot Availablecompleted
NCT04009460
A Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Solid TumorsNo drug interventionstreatment1terminated
NCT02606994
Effect of Over-the-counter Toothpastes on Chemotherapy-induced Oral Mucositistreatment2terminated
NCT02486094
Study of PRoliferation and Apoptosis in Rectal Cancer, Predictive & Prognostic biOmarkers: Histopathology and ImagingNo drug interventionsNot AvailableNot Availablecompleted
NCT00005494
Prospective Study of Health in Runners and WalkersNo drug interventionsNot AvailableNot Availablecompleted
NCT05704894
Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrenstreatment3not_yet_recruiting
NCT00962494
Cancer: Thriving and Surviving Online Workshop and Study for Cancer SurvivorsNo drug interventionssupportive_care2completed
NCT06287294
An Investigation Into Taste Problems Associated With Xerostomia in Patients With Advanced CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT02824094
Crizotinib Expanded Access Protocol For ROS1 Positive NSCLCNot AvailableNot Availableno_longer_available
NCT05999994
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancertreatment2recruiting
NCT02372994
My Team of Care: a Pilot Randomized Controlled Trial of an Online Communication Tool for Collaborative CareNo drug interventionssupportive_careNot Availablecompleted
NCT05895994
Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological MalignanciesNo drug interventionstreatment0recruiting
NCT03564691
Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4830-001)treatment1active_not_recruiting
NCT03797391
A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumorstreatment1 / 2recruiting
NCT00037791
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of ThrombocytopeniaNo drug interventionsprevention3completed
NCT00256191
Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignanciestreatment1completed
NCT00219791
Study of Glucarpidase (CPG2) for the Management of Patients With Delayed Methotrexate Clearancetreatment2completed
NCT03872362
Radiomics Multifactorial Biomarker for Pulmonary NodulesNo drug interventionsNot AvailableNot Availablecompleted
NCT04349280
A Study to Evaluate the Efficacy and Safety of Bintrafusp Alfa (M7824) Monotherapy in Metastatic or Locally Advanced Urothelial Cancertreatment1terminated
NCT00048880
Phase I Study of HeFi-1 to Treat Cancers With CD30 ProteinNo drug interventionstreatment1completed
NCT00135980
Integrated Care for Cancer Patients; Developing, Implementing and Testing a Programme to Improve Integrated CareNo drug interventionseducational_counseling_trainingNot Availableunknown_status
NCT00830180
Open Label Extension In Cancer PatientsNo drug interventionstreatment2completed
NCT01576380
A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patientstreatment2completed
NCT00259129
Effect of BAY 43-9006 (Sorafenib) on Cardiovascular Safety Parameters in Cancer PatientsNot Available1completed
NCT00207129
Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignanciestreatment1completed
NCT03143829
Promoting Cancer Symptom Management in Older AdultsNo drug interventionssupportive_careNot Availablecompleted
NCT04746729
Health Effects of CArdiac FluoRoscopy and MOderN RadIotherapy in PediatriCs - RadiotherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05712889
Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced CancerNo drug interventionstreatment1recruiting
NCT04989192
Dose Efficiency of Modern CT Scanners in Oncologic ScansNo drug interventionsdiagnosticNot Availableunknown_status
NCT05882292
A Phase II Study of ABN401 in Advanced Solid Tumors With c-MET Gene AberrationNo drug interventionstreatment2not_yet_recruiting
NCT05013944
AnovaOS Network Powered Patient RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT00560144
A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.treatment1completed
NCT04991740
A Study of JNJ-78306358 in Participants With Advanced Stage Solid TumorsNo drug interventionstreatment1completed
NCT00046540
Liposome Encapsulated SN38 (LE-SN38) in Patients With Advanced Cancertreatment1completed
NCT06004440
Real World Registry for Use of the Ion Endoluminal SystemNo drug interventionsNot AvailableNot Availablerecruiting
NCT03096340
Safety and Pharmacokinetic Study of IT-141 in Monotherapy in Patients With Advanced CancerNo drug interventionstreatment1terminated
NCT00309140
An Open Label Study of Oral Enzastaurin in Participants With Cancertreatment2completed
NCT03351140
Patient-Reported Outcome Measurement Information System (PROMIS) Physical FunctionNo drug interventionsNot AvailableNot Availablecompleted
NCT05440240
Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's ContractureNo drug interventionstreatment4recruiting
NCT05022667
Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total ThyroidectomyNo drug interventionspreventionNot Availablerecruiting
NCT03336567
Perceptions of Cell and Gene Therapies (CGT) for the Treatment of CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04509167
Pilot Study of Neoantigen Peptides for the Treatment of NeoplasmsNo drug interventionstreatment0completed
NCT00106067
Aging and Family Outcomes in Supportive Care of Advanced Cancer PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT01837667
Phase I Study of LB-100 With Docetaxel in Solid Tumorstreatment1completed
NCT05307367
Cancer-associated Muscle Mass - Molecular Factors and Exercise MechanismsNo drug interventionsbasic_scienceNot Availablerecruiting
NCT01226901
A Phase I Study of MK-4827 for Treatment of Solid Tumors (MK-4827-005)treatment1terminated
NCT02265601
End-of-Life Health Care Decisions by Patients With Advanced CancerNo drug interventionsotherNot Availablecompleted
NCT03329001
Crossover Study to Assess the Relative Bioavailability and Bioequivalence of Niraparib Tablet Compared to Niraparib Capsuletreatment1completed
NCT01186601
Exploration of Tumor Accumulation of BAY94-9392 in Patients With CancerNo drug interventionsdiagnostic1completed
NCT04006301
First-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C MutationNo drug interventionstreatment1completed
NCT03510104
Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid TumorsNo drug interventionstreatment1active_not_recruiting
NCT01339104
Open Label Regorafenib Study to Evaluate Cardiovascular Safety Parameters, Tolerability, and Anti-tumor Activitytreatment1completed
NCT02635672
Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancertreatment1active_not_recruiting
NCT01901172
A Study of the Drug-Drug Interaction of RO5503781 and Posaconazole, the Relative Bioavailability of New Formulations of RO5503781 and the Food-Effect on the Pharmacokinetics of RO5503781 in Patients With Solid TumorsNot Available1completed
NCT02861872
Intra-peritoneal Chemotherapy in Ovarian CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT01973868
Safety and Pharmacokinetics of Regorafenib and Cetuximab in Combinationtreatment1completed
NCT02720068
Study of Favezelimab (MK-4280) as Monotherapy and in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy or Lenvatinib (MK-7902) AND Favezelimab/Pembrolizumab (MK-4280A) as Monotherapy in Adults With Advanced Solid Tumors (MK-4280-001)treatment1completed
NCT00001668
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac TumorsNo drug interventionsNot AvailableNot Availablecompleted
NCT06256068
Determinants of Physical Activity Level in Pediatric Oncological Patients Treated With Cardiotoxic Therapy - a Study ProtocolNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03424668
The European Prospective Investigation Into Cancer in Norfolk Prospective Population StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05160168
A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)treatment1 / 2terminated
NCT02324868
Impact of Availability of Showerpatch for Patients With Intravenous CathetersNo drug interventionssupportive_careNot Availableterminated
NCT03553368
Chest Imaging of Lung Nodule(s) Under High-frequency Non-invasive Ventilation (HF-NIV)No drug interventionsdiagnosticNot Availablecompleted
NCT00880568
Phase I Study of MK-1496 in Patients With Advanced Solid Tumor (MK-1496-002 AM 4)(COMPLETED)treatment1completed
NCT01891669
A Study Of PF-06263507 In Patients With Advanced Solid TumorsNo drug interventionstreatment1terminated
NCT02380469
Improvement of Information to Cancer Patients' CaregiversNo drug interventionshealth_services_researchNot Availablecompleted
NCT05374369
Retrospective Analysis of Colorectal Cancer Screening ResultsNo drug interventionsNot AvailableNot Availablecompleted
NCT01335269
A Study of BI 853520 in Patients With Various Types of Advanced or Metastatic Cancertreatment1completed
NCT01164046
Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolismtreatment3terminated
NCT02341846
Exploring New Technologies to Manage Cancer Pain in the CommunityNo drug interventionsNot AvailableNot Availablecompleted
NCT00264446
A Study of ADH300004 in Surgically Resected Primary or Metastatic Colorectal Cancer and Liver Biopsy, or Planned Hepatic ResectionNo drug interventionstreatment1completed
NCT01472146
ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast Cancertreatment2completed
NCT01591746
Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstructionsupportive_care3completed
NCT01938846
BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumorstreatment1completed
NCT03328546
Dietary Patterns and Health Outcomes (Cardiovascular, Metabolic, Endocrine, Neurological, Skeletal Muscular, Cancer)No drug interventionsNot AvailableNot Availablecompleted
NCT00545246
A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer Patientstreatment1completed
NCT02747212
Measuring the Electrical Properties of Malignant Tissues Ex VivoNo drug interventionsNot AvailableNot Availableunknown_status
NCT06058312
Individual Food Preferences for the Mediterranean Diet in Cancer PatientsNo drug interventionssupportive_careNot Availablerecruiting
NCT02514512
Lung Cancer Radiotherapy Using Realtime Dynamic Multileaf Collimator (MLC) Adaptation And Radiofrequency TrackingNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT02588612
Letetresgene Autoleucel Engineered T Cells in NY-ESO -1 Positive Advanced Non-Small Cell Lung Cancer (NSCLC)treatment1completed
NCT00954512
Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004)treatment1 / 2terminated
NCT03573310
A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDSNo drug interventionstreatment1active_not_recruiting
NCT04085510
Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western PennsylvaniaNo drug interventionsscreeningNot Availableactive_not_recruiting
NCT00566410
A Phase I, Open-Labeled, Single-Arm, Dose Escalation, Clinical and Pharmacology Study of Dichloroacetate (DCA) in Patients With Recurrent and/or Metastatic Solid Tumourstreatment1completed
NCT00300781
Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancertreatment2completed
NCT05538481
Study to Identify and Measure the Values and Palliative Care Pref. of Hindu Patients and Their CaregiversNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00264095
An Observational Study of Blood Management Techniques in Oncology Surgical TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT00001495
A Phase I Study of Irinotecan (CPT-11) Administered as a Prolonged Infusion in Adult Patients With Solid Tumorstreatment1completed
NCT04544995
Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Pediatric Participants With Solid Tumors (SCOOP)treatment1suspended
NCT05209295
A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid Malignanciesbasic_science1recruiting
NCT04448314
Study to Evaluate the Usability of PointCheckNo drug interventionsNot AvailableNot Availablecompleted
NCT03156114
This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.treatment1completed
NCT04465214
Mobile Sensor Technologies to Assess General Symptomology of People With CancerNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT00706355
A Study of PF-04217903 in Patients With Advanced Cancertreatment1terminated
NCT04722055
A Multicenter Clinical Trial of Stool-based DNA Testing for Early Detection of Colon Cancer in ChinaNo drug interventionsNot AvailableNot Availablecompleted
NCT03333655
Study to Explore the Mechanism of Acquired Immune Escape In Participants With Metastatic Cancer Progressing on CPI TherapyNo drug interventionsbasic_science4completed
NCT01657955
Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemiatreatment3unknown_status
NCT03810755
EfiKroniK Research Program: Physical Exercise for People With Chronic PathologiesNo drug interventionstreatmentNot Availablecompleted
NCT01273155
Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunctiontreatment1completed
NCT02723955
Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)treatment1completed
NCT04596150
Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancertreatment2completed
NCT00225550
A Study of the Safety and Effects of ADH-1 Given Daily to Subjects With Solid Tumorstreatment1 / 2terminated
NCT06187350
The Use of AI to Safely Reduce the Workload in Breast Cancer Screening With Mammography in Region ÖstergötlandNo drug interventionsNot AvailableNot Availablerecruiting
NCT05235750
Self-affirmation Intervention for People Newly Diagnosed With Advanced CancerNo drug interventionspreventionNot Availablecompleted
NCT03972150
A Study to Find the Best Dose of BI 836880 Alone and in Combination With BI 754091 in Japanese Patients With Different Types of Advanced Cancertreatment1completed
NCT00034450
Developmental Study on Fatigue in Cancertreatment2completed
NCT02123823
BI 836845 in Estrogen Receptor Positive Metastatic Breast Cancertreatment1completed
NCT01065623
Clinical Study to Evaluate the Maximum Tolerated Dose of BAY79-4620 Given Every 2 Weeks to Patients With Advanced Solid TumorsNo drug interventionstreatment1terminated
NCT01767623
A Study of The Impact of Severe Hepatic Impairment on the Pharmacokinetics and Safety of Vemurafenib in BRAF V600 Mutation-Positive Cancer Participantstreatment1completed
NCT00562523
Sorafenib/Docetaxel Dose Escalation Trialtreatment1completed
NCT03967223
Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumorstreatment2active_not_recruiting
NCT00046423
A Trial of ABI-007 in Patients With Advanced Non-Hematologic Malignanciestreatment1completed
NCT06001723
A Feasibility Study to Determine Whether the Botanical Garden Become a Region of Forest Therapy for Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT05386108
Study of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to ER+/HER-2- Breast Cancertreatment1 / 2recruiting
NCT05553808
Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 1treatment2completed
NCT05153408
(HARMONY) Study of BLU-701 in EGFR-mutant NSCLCtreatment1terminated
NCT00264108
Cost-effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have AnemiaNot AvailableNot Availablecompleted
NCT01081808
Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid TumorsNo drug interventionstreatment1terminated
NCT01322438
Effect of Rifampin on the Pharmacokinetics of BAY73-4506basic_science1completed
NCT04626843
Intermittent Fasting and CLL/SLLNo drug interventionstreatment1completed
NCT04630743
Cognitive and Behavioral Intervention for the Management of Episodic Breathlessness in Patients With Advanced DiseaseNo drug interventionsotherNot Availablecompleted
NCT05592743
Vorasidenib Expanded Access ProgramNot AvailableNot Availableavailable
NCT06128343
Anatomical-Clinical Base of Adenocarcinoma PancreaticNo drug interventionsNot AvailableNot Availablerecruiting
NCT01938443
A Dose Escalation Study to Assess Safety of GSK2256098 (FAK Inhibitor) in Combination With Trametinib (MEK Inhibitor) in Subjects With Advanced Solid Tumorstreatment1completed
NCT03282643
Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patientsprevention1 / 2completed
NCT01214343
Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCCtreatment3unknown_status
NCT03883243
Monitoring and Telecoaching of Physical Activity in Patients With Stage III and IV Non-small Cell Lung CancerNo drug interventionsotherNot Availableunknown_status
NCT00000603
Cord Blood Stem Cell Transplantation Study (COBLT)No drug interventionstreatment2completed
NCT02331303
A Drug Utilization Study of Radium-223 in SwedenNo drug interventionsNot AvailableNot Availablecompleted
NCT04853303
VR to Improve CINV, Sleep and Pain Among Children With Cancer in HKNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT02025803
A Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With Capecitabine in Patients With Advanced Solid Tumorstreatment1completed
NCT00715403
A Phase I/II Open Label Extension Study of BIBF 1120 Administered Orally Once or Twice Daily to Establish Safety, Pharmacokinetics and Efficacy in Patients With Advanced Solid Tumours and Clinical Benefit From Previous Therapy With BIBF 1120treatment1completed
NCT03788603
Rogaratinib (BAY1163877) in Chinese Patientstreatment1completed
NCT03783403
A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancerstreatment1active_not_recruiting
NCT00437203
PF-00477736 Is Being Studied In Advanced Solid Tumors In Combination With Chemotherapy With Gemcitabinetreatment1terminated
NCT02047890
Japanese BAY1000394 Monotherapy Phase I Studytreatment1completed
NCT04198090
Sexual & Gender Minority Competency in OncologyNo drug interventionssupportive_careNot Availablecompleted
NCT00207090
Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancertreatment1completed
NCT00088790
AZD5438 in Patients With Advanced Solid MalignanciesNo drug interventionstreatment1completed
NCT04495790
AIMS Cancer Outcomes StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02241564
Malignancies in Transplanted PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT01373164
A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancertreatment1 / 2completed
NCT01088464
Study of IMC-11F8 in Participants With Advanced Solid Tumorstreatment1completed
NCT03495921
A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomidetreatment3terminated
NCT00210002
Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Inducedprevention2terminated
NCT01324102
Yoga Cancer Rehabilitation Study: A Randomized Trial of Adaptive Yoga for Older Cancer SurvivorsNo drug interventionstreatment1 / 2completed
NCT05573802
A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myelomatreatment1 / 2recruiting
NCT00432302
Investigation of Mass Balance of the Test Drug and Major Metabolitestreatment1completed
NCT00507702
Identification of Key Blood Molecular Markers for ImmunotherapyNo drug interventionsNot AvailableNot Availableterminated
NCT04260802
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancerstreatment1 / 2recruiting
NCT02171702
Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumourstreatment1completed
NCT03895502
Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Studytreatment4completed
NCT01567384
A Phase I Study of OSI-906 in Combination With Pemetrexed in Advanced Solid Tumor Malignanciestreatment1withdrawn
NCT00879684
Safety And PK Study Of CVX-060 In Patients With Advanced Solid TumorsNo drug interventionstreatment1completed
NCT06376084
Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLCNo drug interventionsNot AvailableNot Availablerecruiting
NCT02314884
Phase I Trial to Investigate Cafusertib Hydrochloride Monotherapy in Chinese Patients With Advanced Solid TumoursNo drug interventionstreatment1unknown_status
NCT01588184
An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Studytreatment4completed
NCT04309084
Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myelomatreatment1active_not_recruiting
NCT00779584
A Dose-escalation Study of MK-8776 (SCH 900776) With and Without Gemcitabine in Participants With Solid Tumors or Lymphoma (MK-8776-002/P05248)treatment1completed
NCT04300179
Ewing Sarcoma Family of Tumors (ESFT): A 15-year Experience From a Tertiary Care Cancer Center in Upper EgyptNo drug interventionsNot AvailableNot Availablecompleted
NCT02429479
Preparing Family Caregivers to Make Medical Decisions for Their Loved OnesNo drug interventionssupportive_careNot Availablecompleted
NCT05347979
Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participantstreatment1completed
NCT00730379
A Combination Study With Ridaforolimus (MK8669) and Dalotuzumab (MK0646) in Patients With Advanced Cancer (8669-004)treatment1completed
NCT00385879
The Effects of Case Management in a Medicaid Managed Care PlanNo drug interventionssupportive_careNot Availableunknown_status
NCT06322693
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)treatment1recruiting
NCT04545827
Study to Evaluate the Safety of IMM-01 in Patients With Advanced Solid Tumoursbasic_science1not_yet_recruiting
NCT03816254
A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, With Cetuximab in Subjects With Advanced Solid Cancerstreatment1not_yet_recruiting
NCT02810431
Long Term Retention of Protspectively Obtained BiospecimensNo drug interventionsNot AvailableNot Availablecompleted